{ "CurrentPageLength": 100, "CurrentStartItemIndex": 0, "Items": [ { "Id": "media-27828", "ContentId": "27828", "Headline": "Proactive - CelLBxHealth, Caledonia Mining, Rome Resources, European Green Transition, International Biotechnology Trust, Pantheon International - Small Cap Week in Review", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/27828", "ThumbnailUrl": "https://img.youtube.com/vi/6ZB7P5e7EAw/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2026-05-16T08:30:04", "LastModifiedDateTime": "2026-05-16T09:16:19.023" }, { "Id": "media-27793", "ContentId": "27793", "Headline": "Proactive - CelLBxHealth targets growth after £6.6m cost-cutting overhaul", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/27793", "ThumbnailUrl": "https://img.youtube.com/vi/2MUZdyRfL9Y/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2026-05-12T07:35:00", "LastModifiedDateTime": "2026-05-12T09:05:10.93" }, { "Id": "media-27787", "ContentId": "27787", "Headline": "Proactive - CelLBxHealth, Poolbeg Pharma, Caledonia Mining, Empire Metals, 88 Energy, Atlantic Lithium", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/27787", "ThumbnailUrl": "https://img.youtube.com/vi/w2_O4yo61KM/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2026-05-11T08:55:00", "LastModifiedDateTime": "2026-05-11T10:05:06.457" }, { "Id": "research-129_f2950add-36ca-4b97-8f5c-74de6a1181ce", "ContentId": "129_f2950add-36ca-4b97-8f5c-74de6a1181ce", "Headline": "Cavendish - Morning Note – 11 May 2026", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-11-may-2026/129_f2950add-36ca-4b97-8f5c-74de6a1181ce?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ca5de4b5-06e9-4de9-87a6-17f0ad24fca7-stock-market-prices-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "88 Energy Limited", "CompanyUrl": "https://www.research-tree.com/companies/uk/energy/88-energy-limited/88E/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Oil & Gas" ], "Id": "AU00000088E2", "InternalId": "491a4860-4dfb-4838-8e24-03ceee5691fc", "Isin": "AU00000088E2", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Oil & Gas - Integrated", "Ticker": "88E:LON", "TIDM": "88E", "BBTicker": "88E", "AltTicker": "88E", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 7, "TotalResearchCount": 356, "TotalRnsCount": 749 }, { "CompanyName": "4basebio PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/4basebio-plc/4BB/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Pharmaceuticals & Biotechnology" ], "Id": "FQB1TH-R", "InternalId": "e61ebbbf-9a78-4360-9ebf-9b4a6d526f3c", "Isin": "GB00BMCLYF79", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Biotechnology", "Ticker": "4BB:LON", "TIDM": "4BB", "BBTicker": "4BB", "AltTicker": "4BB", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 0, "TotalResearchCount": 38, "TotalRnsCount": 136 }, { "CompanyName": "Pennant International Group plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/technology/pennant-international-group-plc/PEN/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Software & Computer Services" ], "Id": "GB0002570660", "InternalId": "bdfcee6b-fb36-427b-bbb1-7db08dfe8d15", "Isin": "GB0002570660", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Software", "Ticker": "PEN:LON", "TIDM": "PEN", "BBTicker": "PEN", "AltTicker": "PEN", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 4, "TotalResearchCount": 117, "TotalRnsCount": 265 }, { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Reabold Resources plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/energy/reabold-resources-plc/RBD/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Oil & Gas" ], "Id": "GB00B95L0551", "InternalId": "bed569cf-501b-4c21-a9c2-20c96cf0fc2a", "Isin": "GB00B95L0551", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Oil & Gas - E&Ps", "Ticker": "RBD:LON", "TIDM": "RBD", "BBTicker": "RBD", "AltTicker": "RBD", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 3, "TotalEventCount": 0, "TotalMediaCount": 36, "TotalResearchCount": 90, "TotalRnsCount": 479 }, { "CompanyName": "Ultimate Products PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/industrial-equipment-goods-services/ultimate-products-plc/ULTP/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Household Goods & Home Construction" ], "Id": "GB00BYX7MG58", "InternalId": "d44ebb25-e9a2-4c8b-b343-2a1173ca9bcc", "Isin": "GB00BYX7MG58", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Electrical and Electronic Equipment", "Ticker": "ULTP:LON", "TIDM": "ULTP", "BBTicker": "ULTP", "AltTicker": "ULTP", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 1, "TotalEventCount": 12, "TotalMediaCount": 24, "TotalResearchCount": 100, "TotalRnsCount": 640 }, { "CompanyName": "Caledonia Mining Corporation PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/resources/caledonia-mining-corporation-plc/CMCL/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Mining" ], "Id": "JE00BF0XVB15", "InternalId": "f79ab7d8-fd97-4682-83b8-5b3bd68a82d0", "Isin": "JE00BF0XVB15", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Precious Metals", "Ticker": "CMCL:LON", "TIDM": "CMCL", "BBTicker": "CMCL", "AltTicker": "CMCL", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 2, "TotalEventCount": 2, "TotalMediaCount": 72, "TotalResearchCount": 91, "TotalRnsCount": 354 }, { "CompanyName": "Poolbeg Pharma PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/poolbeg-pharma-plc/POLB/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Pharmaceuticals & Biotechnology" ], "Id": "VQQX5T-R", "InternalId": "d2338c56-fad1-46ec-851d-6862214479b9", "Isin": "GB00BKPG7Z60", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Pharmaceuticals", "Ticker": "POLB:LON", "TIDM": "POLB", "BBTicker": "POLB", "AltTicker": "POLB", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 9, "TotalMediaCount": 68, "TotalResearchCount": 82, "TotalRnsCount": 160 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2026-05-11T07:36:56.497", "LastModifiedDateTime": "2026-05-11T07:36:56.463" }, { "Id": "research-129_f2715a94-9e83-48af-b93f-04cf7d1caac2", "ContentId": "129_f2715a94-9e83-48af-b93f-04cf7d1caac2", "Headline": "Cavendish - CelLBxHealth - 1Q26 trading update: Transformation continues", "Synopsis": "CelLBxHealth has released a first quarter trading update for the three months to end March 2026. The period reflects the ongoing operational transformation within the business, most notably additional actions to right‑size the cost base, including further headcount reductions, with these activities expected to reduce annual cash operating costs by £6.6m during 2026. Cash at end‑1Q was £4.3m, in-line with expectations. While notable progress has been made in the internal transformation as the bus", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/cavendish/cellbxhealth-1q26-trading-update-transformation-continues/129_f2715a94-9e83-48af-b93f-04cf7d1caac2?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/7f97e0ca-09a8-4bfa-8b3f-5448a65a8acb-medical-equipment-services-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2026-05-11T07:15:44.943", "LastModifiedDateTime": "2026-05-11T07:38:33.237" }, { "Id": "media-27631", "ContentId": "27631", "Headline": "Proactive - CelLBxHealth, Genflow, Active Energy, Caledonia Mining, Great Southern Copper, Rome Resources - Small Cap Snapshot", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/27631", "ThumbnailUrl": "https://img.youtube.com/vi/FT32z28rrSY/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2026-04-20T09:45:00", "LastModifiedDateTime": "2026-04-20T11:05:52.567" }, { "Id": "research-129_fa17a097-e2da-4db2-b5a2-42749fe2b39c", "ContentId": "129_fa17a097-e2da-4db2-b5a2-42749fe2b39c", "Headline": "Cavendish - Morning Note – 20 April 2026", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-20-april-2026/129_fa17a097-e2da-4db2-b5a2-42749fe2b39c?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/b579ca8e-bcca-466a-9b40-4c340fdc48b0-financial-ticker-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Nanoco Group PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/technology/nanoco-group-plc/NANO/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Tech Hardware & Equipment" ], "Id": "GB00B01JLR99", "InternalId": "55251176-6c9d-4917-b9e6-b2d9198cc606", "Isin": "GB00B01JLR99", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Semiconductors", "Ticker": "NANO:LON", "TIDM": "NANO", "BBTicker": "NANO", "AltTicker": "NANO", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 8, "TotalEventCount": 0, "TotalMediaCount": 13, "TotalResearchCount": 103, "TotalRnsCount": 587 }, { "CompanyName": "Elixirr International Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/other/elixirr-international-plc/ELIX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Business Services" ], "Id": "GB00BLPHTX84", "InternalId": "90e61e79-97f2-44ed-979e-dacad8a18d2f", "Isin": "GB00BLPHTX84", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Other", "Ticker": "ELIX:LON", "TIDM": "ELIX", "BBTicker": "ELIX", "AltTicker": "ELIX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 4, "TotalMediaCount": 1, "TotalResearchCount": 64, "TotalRnsCount": 145 }, { "CompanyName": "Cordel Group PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/technology/cordel-group-plc/CRDL/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Tech Hardware & Equipment" ], "Id": "GB00BYZQM590", "InternalId": "ab4727f5-3884-4c8c-9022-935dfaf4c063", "Isin": "GB00BYZQM590", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "IT services", "Ticker": "CRDL:LON", "TIDM": "CRDL", "BBTicker": "CRDL", "AltTicker": "CRDL", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 1, "TotalEventCount": 0, "TotalMediaCount": 12, "TotalResearchCount": 78, "TotalRnsCount": 236 }, { "CompanyName": "Caledonia Mining Corporation PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/resources/caledonia-mining-corporation-plc/CMCL/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Mining" ], "Id": "JE00BF0XVB15", "InternalId": "f79ab7d8-fd97-4682-83b8-5b3bd68a82d0", "Isin": "JE00BF0XVB15", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Precious Metals", "Ticker": "CMCL:LON", "TIDM": "CMCL", "BBTicker": "CMCL", "AltTicker": "CMCL", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 2, "TotalEventCount": 2, "TotalMediaCount": 72, "TotalResearchCount": 91, "TotalRnsCount": 354 }, { "CompanyName": "Cora Gold Ltd.", "CompanyUrl": "https://www.research-tree.com/companies/uk/resources/cora-gold-ltd-/CORA/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Mining" ], "Id": "VGG2423W1077", "InternalId": "3606e741-936d-46c1-974c-a40270bb3d21", "Isin": "CQH42S-R ", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Precious Metals", "Ticker": "CORA:LON", "TIDM": "CORA", "BBTicker": "CORA", "AltTicker": "CORA", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 11, "TotalResearchCount": 53, "TotalRnsCount": 277 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2026-04-20T07:28:38.597", "LastModifiedDateTime": "2026-04-20T07:33:25.547" }, { "Id": "research-129_4ee8a429-84ce-4a23-bb7f-98c227762a88", "ContentId": "129_4ee8a429-84ce-4a23-bb7f-98c227762a88", "Headline": "Cavendish - CelLBxHealth - Study collaboration with The Royal Marsden", "Synopsis": "CelLBxHealth has announced a research collaboration with The Royal Marsden NHS Foundation Trust, one of the world’s leading cancer centres, to evaluate the clinical utility of its CTC‑DNA technology in blood samples from patients with advanced lung cancer. The study targets a clearly defined and underserved patient cohort, those with uninformative ctDNA results, and represents an important validation step for CelLBxHealth’s proposition that CTC‑derived DNA can provide additional, actionable geno", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/cavendish/cellbxhealth-study-collaboration-with-the-royal-marsden/129_4ee8a429-84ce-4a23-bb7f-98c227762a88?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/76271257-b7ad-42c7-b4b4-f8ee4d725a4f-medical-equipment-services-3-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2026-04-20T07:23:59.393", "LastModifiedDateTime": "2026-04-20T07:23:59.08" }, { "Id": "research-129_89fb7ea8-ac5f-4517-b14a-43591e6d6ba7", "ContentId": "129_89fb7ea8-ac5f-4517-b14a-43591e6d6ba7", "Headline": "Cavendish - Morning Note – 13 February 2026", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-13-february-2026/129_89fb7ea8-ac5f-4517-b14a-43591e6d6ba7?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ca5de4b5-06e9-4de9-87a6-17f0ad24fca7-stock-market-prices-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "SDI Group plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/industrial-equipment-goods-services/sdi-group-plc/SDI/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare Equipment & Services" ], "Id": "GB00B3FBWW43", "InternalId": "faf8097e-e8b4-4f82-bfa9-60c0b393fa49", "Isin": "GB00B3FBWW43", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Electrical and Electronic Equipment", "Ticker": "SDI:LON", "TIDM": "SDI", "BBTicker": "SDI", "AltTicker": "SDI", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 9, "TotalEventCount": 2, "TotalMediaCount": 3, "TotalResearchCount": 151, "TotalRnsCount": 262 }, { "CompanyName": "Nexteq PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/discretionary-personal-goods/nexteq-plc/NXQ/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Tech Hardware & Equipment" ], "Id": "GB00B99PCP71", "InternalId": "798447de-596e-4512-9f92-fa4b8a624d01", "Isin": "GB00B99PCP71", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Lifestyle Products", "Ticker": "NXQ:LON", "TIDM": "NXQ", "BBTicker": "NXQ", "AltTicker": "NXQ", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 3, "TotalEventCount": 0, "TotalMediaCount": 10, "TotalResearchCount": 125, "TotalRnsCount": 435 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2026-02-13T07:25:58.81", "LastModifiedDateTime": "2026-02-13T07:42:16.68" }, { "Id": "research-129_3fb6ca7d-925a-4e86-acf8-28f5f7a2468a", "ContentId": "129_3fb6ca7d-925a-4e86-acf8-28f5f7a2468a", "Headline": "Cavendish - CelLBxHealth - Regulatory realignment strengthens cost control efforts", "Synopsis": "CelLBxHealth has announced its strategic decision to discontinue the costs of maintaining its FDA establishment licence and device listing for the Parsortix system. Given Parsortix’s major use in the field currently lies within in-house research and assay development applications (>97%), management does not see the FDA designation as providing any commercial benefit. The device listing may be reinstated, with the payment of applicable annual fees, at a later point in time if deemed to be of comm", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/cavendish/cellbxhealth-regulatory-realignment-strengthens-cost-control-efforts/129_3fb6ca7d-925a-4e86-acf8-28f5f7a2468a?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/158fe0c8-21a5-4739-9ea5-1180902cbdbd-medical-equipment-services-5-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2026-02-13T07:08:27.017", "LastModifiedDateTime": "2026-02-13T07:09:19.513" }, { "Id": "research-129_53af5746-14e6-41e7-9d23-b43a305310c4", "ContentId": "129_53af5746-14e6-41e7-9d23-b43a305310c4", "Headline": "Cavendish - CelLBxHealth - Trading Update: FY26-28E forecasts maintained", "Synopsis": "CelLBxHealth has provided a trading update for the year ended 31 December 2025. The group is expected to deliver FY25 revenues of £1.4m, slightly below our estimates of £1.6m as a result of some sales contracts with an aggregate value of c£0.2m being deferred into 1Q26. The company’s cash position has also been further bolstered following completion of the recent (December 2025) equity financing, raising total gross proceeds of c£8.6m, with reported year-end cash of £7.3m. We have updated FY25E ", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/cavendish/cellbxhealth-trading-update-fy26-28e-forecasts-maintained/129_53af5746-14e6-41e7-9d23-b43a305310c4?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/7f97e0ca-09a8-4bfa-8b3f-5448a65a8acb-medical-equipment-services-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2026-01-19T10:08:55.533", "LastModifiedDateTime": "2026-01-19T10:08:55.487" }, { "Id": "research-129_2cb8e63d-e619-4d4d-895a-9bf88622bd5e", "ContentId": "129_2cb8e63d-e619-4d4d-895a-9bf88622bd5e", "Headline": "Cavendish - Morning Note – 16 January 2026", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-16-january-2026/129_2cb8e63d-e619-4d4d-895a-9bf88622bd5e?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ca5de4b5-06e9-4de9-87a6-17f0ad24fca7-stock-market-prices-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Pathos Communications Limited", "CompanyUrl": "https://www.research-tree.com/companies/uk/media/pathos-communications-limited/NEWS/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Media" ], "Id": "X6RCD4-R", "InternalId": "e25422eb-e6bc-4225-82c7-83cbe32ad0d9", "Isin": "GB00BTWSXW71", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Multiservice Media Agencies", "Ticker": "NEWS:LON", "TIDM": "NEWS", "BBTicker": "NEWS", "AltTicker": "NEWS", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 2, "TotalMediaCount": 1, "TotalResearchCount": 6, "TotalRnsCount": 20 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2026-01-16T07:26:50.703", "LastModifiedDateTime": "2026-01-16T07:31:39.587" }, { "Id": "research-129_2928e54c-ae81-4560-aa4c-677c543a30ff", "ContentId": "129_2928e54c-ae81-4560-aa4c-677c543a30ff", "Headline": "Cavendish - CelLBxHealth - Accelerating the commercial ramp up of Parsortix", "Synopsis": "With a new, highly experienced and commercially focused management team, CelLBxHealth is focused on accelerating the commercial rollout of its Parsortix circulating tumour cell (CTC) capture platform and related services. To facilitate these commercialisation efforts and to assist in a near-term corporate restructure, CelLBxHealth has conditionally raised gross proceeds of £6.8m through a proposed equity placing with the potential to raise a further £1.0m through a retail and open offer. In para", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/cavendish/cellbxhealth-accelerating-the-commercial-ramp-up-of-parsortix/129_2928e54c-ae81-4560-aa4c-677c543a30ff?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/7f97e0ca-09a8-4bfa-8b3f-5448a65a8acb-medical-equipment-services-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-11-25T08:08:07.97", "LastModifiedDateTime": "2025-11-25T08:41:13.327" }, { "Id": "media-25562", "ContentId": "25562", "Headline": "Proactive - CelLBxHealth, Bluefield Solar Income Fund, Oriole Resources, Union Jack Oil, Caledonia Mining - Small Cap Snapshot", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/25562", "ThumbnailUrl": "https://img.youtube.com/vi/lRfLGdSyD5I/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-11-05T09:05:00", "LastModifiedDateTime": "2025-11-05T10:06:31.87" }, { "Id": "media-25555", "ContentId": "25555", "Headline": "Proactive - CelLBxHealth, Arecor Therapeutics, Kodal Minerals, Diversified Energy, Ariana Resources - Small Cap Snapshot", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/25555", "ThumbnailUrl": "https://img.youtube.com/vi/OENu9dxV1so/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-11-04T09:05:00", "LastModifiedDateTime": "2025-11-04T10:08:04.257" }, { "Id": "research-129_6585ded3-4cf9-442c-84ba-3aebfa2aff0d", "ContentId": "129_6585ded3-4cf9-442c-84ba-3aebfa2aff0d", "Headline": "Cavendish - Morning Note – 29 September 2025", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-29-september-2025/129_6585ded3-4cf9-442c-84ba-3aebfa2aff0d?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/b579ca8e-bcca-466a-9b40-4c340fdc48b0-financial-ticker-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "4basebio PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/4basebio-plc/4BB/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Pharmaceuticals & Biotechnology" ], "Id": "FQB1TH-R", "InternalId": "e61ebbbf-9a78-4360-9ebf-9b4a6d526f3c", "Isin": "GB00BMCLYF79", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Biotechnology", "Ticker": "4BB:LON", "TIDM": "4BB", "BBTicker": "4BB", "AltTicker": "4BB", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 0, "TotalResearchCount": 38, "TotalRnsCount": 136 }, { "CompanyName": "Ebiquity Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/other/ebiquity-plc/EBQ/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Media" ], "Id": "GB0004126057", "InternalId": "ec516b06-f755-439b-9f97-c012c2488168", "Isin": "GB0004126057", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Other", "Ticker": "EBQ:LON", "TIDM": "EBQ", "BBTicker": "EBQ", "AltTicker": "EBQ", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 2, "TotalEventCount": 0, "TotalMediaCount": 7, "TotalResearchCount": 49, "TotalRnsCount": 327 }, { "CompanyName": "Solid State plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/discretionary-personal-goods/solid-state-plc/SOLI/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Industrials" ], "Id": "GB0008237132", "InternalId": "9f9de74d-f9bc-4e50-a3ad-2f36d3e93c4b", "Isin": "GB0008237132", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Electronic Products", "Ticker": "SOLI:LON", "TIDM": "SOLI", "BBTicker": "SOLI", "AltTicker": "SOLI", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 6, "TotalEventCount": 4, "TotalMediaCount": 8, "TotalResearchCount": 251, "TotalRnsCount": 256 }, { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Seascape Energy Asia PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/energy/seascape-energy-asia-plc/SEA/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Oil & Gas" ], "Id": "GB00BKFW2482", "InternalId": "db18112c-71e7-4b43-95a9-e945eb987d3b", "Isin": "GB00BKFW2482", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Oil & Gas - Services", "Ticker": "SEA:LON", "TIDM": "SEA", "BBTicker": "SEA", "AltTicker": "SEA", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 3, "TotalResearchCount": 84, "TotalRnsCount": 236 }, { "CompanyName": "Duke Capital Limited", "CompanyUrl": "https://www.research-tree.com/companies/uk/financial-services/duke-capital-limited/DUKE/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Financial Services" ], "Id": "GG00BYZSSY63", "InternalId": "737653b3-0bd4-41dd-b367-0c614a838929", "Isin": "GG00BYZSSY63", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Asset Management", "Ticker": "DUKE:LON", "TIDM": "DUKE", "BBTicker": "DUKE", "AltTicker": "DUKE", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 3, "TotalEventCount": 5, "TotalMediaCount": 6, "TotalResearchCount": 85, "TotalRnsCount": 319 }, { "CompanyName": "Poolbeg Pharma PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/poolbeg-pharma-plc/POLB/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Pharmaceuticals & Biotechnology" ], "Id": "VQQX5T-R", "InternalId": "d2338c56-fad1-46ec-851d-6862214479b9", "Isin": "GB00BKPG7Z60", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Pharmaceuticals", "Ticker": "POLB:LON", "TIDM": "POLB", "BBTicker": "POLB", "AltTicker": "POLB", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 9, "TotalMediaCount": 68, "TotalResearchCount": 82, "TotalRnsCount": 160 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-09-29T08:07:40.307", "LastModifiedDateTime": "2025-09-29T08:48:07.323" }, { "Id": "research-129_7384b2f8-4817-446a-a567-60e558ac799a", "ContentId": "129_7384b2f8-4817-446a-a567-60e558ac799a", "Headline": "Cavendish - ANGLE - Further clinical evidence for Parsortix in glioblastoma", "Synopsis": "ANGLE has announced the presentation of new Parsortix system data from a proof-of-concept study in patients with the aggressive brain cancer glioblastoma (GBM) at the 7th Advances in Circulating Tumour Cells (ACTC) meeting. The poster presentation reported data from 15 newly diagnosed, treatment-naïve (no prior treatment) GBM patients whose blood was processed using the Parsortix system. The key findings from the study were: (i) CTCs were found in 60% of patients, with clusters, known to carry h", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/cavendish/angle-further-clinical-evidence-for-parsortix-in-glioblastoma/129_7384b2f8-4817-446a-a567-60e558ac799a?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/7f97e0ca-09a8-4bfa-8b3f-5448a65a8acb-medical-equipment-services-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-09-29T07:14:50.757", "LastModifiedDateTime": "2025-09-29T07:19:13.953" }, { "Id": "research-129_376b1603-0a9a-4a6c-a572-518b21f71887", "ContentId": "129_376b1603-0a9a-4a6c-a572-518b21f71887", "Headline": "Cavendish - ANGLE - Pioneering liquid biopsy solutions for cancer", "Synopsis": "We initiate coverage of ANGLE, a revenue generating specialist diagnostics company focused on advancing, and commercialising, new approaches to liquid (blood) biopsy testing in cancer. ANGLE’s flagship product is the Parsortix system, a unique, cell separation system that captures and harvests circulating tumour cells (CTCs) from blood, allowing in-depth, repeatable downstream analysis of a patient’s cancer. We believe ANGLE’s equity story is now one centred on commercial execution, with top-lin", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/cavendish/angle-pioneering-liquid-biopsy-solutions-for-cancer/129_376b1603-0a9a-4a6c-a572-518b21f71887?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ae21bb63-22c4-4021-9a2f-1eba5a64697a-medical-equipment-services-4-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-09-09T11:12:25.803", "LastModifiedDateTime": "2025-09-09T11:15:53.19" }, { "Id": "research-33_e0d59830-bb62-4254-b3de-ac38447b772b", "ContentId": "33_e0d59830-bb62-4254-b3de-ac38447b772b", "Headline": "Trinity Delta Lighthouse: ANGLE", "Synopsis": "Trinity Delta view: ANGLE’s strategy centres on growing its Pharma Services as it seeks to widen commercial adoption of its proprietary Parsortix technology for CTC capture and subsequent downstream analysis. The marketing focus shifted a year ago towards the better-resourced large pharma customers where, despite more complex selling cycles, there is the potential to drive significant mid- and longer-term revenues. An analogous approach is addressing medtech diagnostics companies to support development of new assays and/or companion diagnostics. There is increasing clinical acceptance that CTC-driven diagnostics can provide complementary actionable information to current liquid biopsy methods, such as ctDNA, including invaluable additional insights that such methods alone cannot. However, headwinds affecting the diagnostics sector remain and ANGLE is not immune to these. As usual following H125 results and updated guidance, we suspend our forecasts and valuation pending review; for context, our prior valuation was £118m, or 37p per share.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/trinity-delta-lighthouse-angle/33_e0d59830-bb62-4254-b3de-ac38447b772b?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/7f97e0ca-09a8-4bfa-8b3f-5448a65a8acb-medical-equipment-services-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-09-09T07:47:33.13", "LastModifiedDateTime": "2025-09-09T07:47:33.1" }, { "Id": "media-25114", "ContentId": "25114", "Headline": "Proactive - ANGLE PLC, Ilika, Genflow Biosciences, Seeing Machines, Thor Explorations, Valereum - Small Cap Week in Review", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/25114", "ThumbnailUrl": "https://img.youtube.com/vi/6wyuSL74_ps/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-08-23T08:30:05", "LastModifiedDateTime": "2025-08-23T09:10:44.637" }, { "Id": "media-25097", "ContentId": "25097", "Headline": "Proactive - ANGLE CEO on breakthrough liquid biopsy partnership with Myriad Genetics", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/25097", "ThumbnailUrl": "https://img.youtube.com/vi/XVCX9ViljnU/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-08-20T14:00:00", "LastModifiedDateTime": "2025-08-21T07:10:00.193" }, { "Id": "media-25095", "ContentId": "25095", "Headline": "Proactive - ANGLE PLC, Costain Group, Jadestone Energy, Sundae Bar - Small Cap Snapshot", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/25095", "ThumbnailUrl": "https://img.youtube.com/vi/pLJk3uvN2gE/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-08-20T09:05:00", "LastModifiedDateTime": "2025-08-20T10:25:55.603" }, { "Id": "research-33_1de8d7ac-f073-4cac-9d98-ab8bc2f58ca0", "ContentId": "33_1de8d7ac-f073-4cac-9d98-ab8bc2f58ca0", "Headline": "Trinity Delta - ANGLE: Priming the Pharma Services market", "Synopsis": "ANGLE’s strategic priority remains firmly on growing and augmenting its Pharma Services offering as it seeks to widen commercial adoption of its proprietary Parsortix technology for CTC capture and subsequent downstream analysis. The power of liquid biopsy to inform personalised cancer therapy is becoming better appreciated, with CTC analysis providing valuable insights that ctDNA analysis cannot. Pharma Services has the potential to drive significant mid- and longer-term revenues, and there are opportunities to explore a similar business model in medtech diagnostics. While the Pharma Services pipeline is healthy and multiple discussions with existing and new prospective partners are progressing, deal execution is binary with uncertain timing. Nevertheless, a sizeable deal could be financially transformative: extending the cash runway beyond Q126, boosting near-term revenues, and moving ANGLE towards cashflow positive trading. Our DCF-based valuation is £118m, or 37p/share.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/angle-priming-the-pharma-services-market/33_1de8d7ac-f073-4cac-9d98-ab8bc2f58ca0?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/4416f982-74ce-4bbf-8c59-67fbe2fa32fd-medical-equipment-services-2-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-06-11T11:06:17.633", "LastModifiedDateTime": "2025-06-11T11:06:17.457" }, { "Id": "research-33_c2dbf6dd-9ea0-499d-9e3e-c7f012873032", "ContentId": "33_c2dbf6dd-9ea0-499d-9e3e-c7f012873032", "Headline": "Trinity Delta Lighthouse: ANGLE", "Synopsis": "Trinity Delta view: ANGLE’s Pharma Services business centres on helping large pharma customers identify cancer mutations as potential biomarkers and use them to guide targeted therapy at any stage from diagnosis to longitudinal monitoring, allowing minimally invasive and repeatable sampling, unlike tissue biopsy. ANGLE’s continued focus on growing and augmenting this offering has the potential to drive significant mid- and longer-term revenues through later-stage clinical development as part of existing deals (depth), cross-selling (breadth), and new deals (halo). Recently, opportunities to widen adoption of Parsortix-based CTC capture and analysis through a similar model for medtech diagnostics companies has been identified, that could help support development of new and/or companion diagnostics (potentially enhancing existing diagnostic solutions). As is usual following FY24 results and updated guidance, we suspend our forecasts and valuation pending review; for context, our prior valuation was £155m, equivalent to 48p per share.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/trinity-delta-lighthouse-angle/33_c2dbf6dd-9ea0-499d-9e3e-c7f012873032?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/158fe0c8-21a5-4739-9ea5-1180902cbdbd-medical-equipment-services-5-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-05-28T07:30:16.3", "LastModifiedDateTime": "2025-05-28T07:30:16.27" }, { "Id": "research-33_80f4136d-a8f4-4c6e-bdea-fa259d3da26d", "ContentId": "33_80f4136d-a8f4-4c6e-bdea-fa259d3da26d", "Headline": "Trinity Delta Lighthouse: ANGLE", "Synopsis": "Trinity Delta view: ANGLE’s focus is on progressing and growing the Pharma Services business, which has the potential to drive significant mid- and longer-term revenues through later-stage development as part of existing deals (depth), cross-selling (breadth), and new deals (halo). This a key element in widening adoption of Parsortix-based CTC analysis to support development of new therapies and potentially broaden the applicability of existing targeted drugs. Cancer mutations as potential biomarkers could guide targeted therapy at any stage from diagnosis to longitudinal monitoring, allowing minimally invasive and repeatable sampling, unlike tissue biopsy. Further confirmation that ANGLE’s assays can assess patient treatment response and identify patients likely to respond to a targeted therapy is another positive. Large pharma validation of its AR, DDR micronuclei, and HER2 CTC assays should help secure new Pharma Services contracts by providing customers with a broader menu of CTC assays across several cancers. Our ANGLE valuation is £155m, equivalent to 48p per share.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/trinity-delta-lighthouse-angle/33_80f4136d-a8f4-4c6e-bdea-fa259d3da26d?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ae21bb63-22c4-4021-9a2f-1eba5a64697a-medical-equipment-services-4-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-03-24T07:34:35.597", "LastModifiedDateTime": "2025-03-24T07:34:35.58" }, { "Id": "media-23593", "ContentId": "23593", "Headline": "Proactive - ANGLE says novel research highlights importance of Parsortix in cancer progression", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/23593", "ThumbnailUrl": "https://img.youtube.com/vi/-bU7dwjGBKU/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-02-06T11:05:50", "LastModifiedDateTime": "2025-02-06T11:09:31.307" }, { "Id": "media-23596", "ContentId": "23596", "Headline": "Proactive - ANGLE says novel research highlights importance of Parsortix in cancer progression", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/23596", "ThumbnailUrl": "https://img.youtube.com/vi/-bU7dwjGBKU/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-02-06T11:05:00", "LastModifiedDateTime": "2025-02-06T12:08:09.84" }, { "Id": "research-33_0ff5a94a-a4f7-4554-b109-8c40db3d9e62", "ContentId": "33_0ff5a94a-a4f7-4554-b109-8c40db3d9e62", "Headline": "Trinity Delta Lighthouse: ANGLE", "Synopsis": "Trinity Delta view: ANGLE’s collaboration with Illumina, the global leader in next-generation sequencing systems and assays, has significant potential to expand the Parsortix commercial opportunity. Liquid biopsy centred on ctDNA analysis is already widely adopted and these recent studies confirm that Parsortix-enabled dual CTC-DNA and ctDNA analysis can provide additional complementary information for cancer diagnosis and longitudinal monitoring. Establishing an optimised end-to-end workflow for simultaneous analysis is a key step towards supporting Illumina’s customers and offering CTC analysis for DNA dual analysis NGS. In our view, these developments should also help secure new Pharma Services contracts - a key strategic objective for ANGLE - by providing these customers with a sample-to-answer solution that delivers comprehensive molecular insights across many cancers to help guide targeted therapy. Our ANGLE valuation is £155m, equivalent to 48p per share.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/trinity-delta-lighthouse-angle/33_0ff5a94a-a4f7-4554-b109-8c40db3d9e62?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/7f97e0ca-09a8-4bfa-8b3f-5448a65a8acb-medical-equipment-services-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-01-30T13:29:40.29", "LastModifiedDateTime": "2025-01-30T13:29:40.267" }, { "Id": "media-23503", "ContentId": "23503", "Headline": "Proactive - ANGLE PLC’s dual DNA workflow breakthrough with Illumina", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/23503", "ThumbnailUrl": "https://img.youtube.com/vi/qaRjlUQ0uAU/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-01-29T09:00:20", "LastModifiedDateTime": "2025-01-29T09:03:57.817" }, { "Id": "media-23507", "ContentId": "23507", "Headline": "Proactive - ANGLE PLC’s dual DNA workflow breakthrough with Illumina", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/23507", "ThumbnailUrl": "https://img.youtube.com/vi/qaRjlUQ0uAU/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-01-29T09:00:00", "LastModifiedDateTime": "2025-01-29T10:11:46.327" }, { "Id": "media-23512", "ContentId": "23512", "Headline": "Proactive - ANGLE’s dual DNA workflow breakthrough with Illumina", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/23512", "ThumbnailUrl": "https://img.youtube.com/vi/qaRjlUQ0uAU/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-01-29T09:00:00", "LastModifiedDateTime": "2025-01-29T13:08:58.703" }, { "Id": "media-23475", "ContentId": "23475", "Headline": "Proactive - ANGLE PLC says Nature Medicine journal highlights Parsortix's role in cancer breakthrough", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/23475", "ThumbnailUrl": "https://img.youtube.com/vi/olB0eo_iYcA/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-01-24T10:05:57", "LastModifiedDateTime": "2025-01-24T10:12:47.167" }, { "Id": "media-23478", "ContentId": "23478", "Headline": "Proactive - ANGLE PLC says Nature Medicine journal highlights Parsortix's role in cancer breakthrough", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/23478", "ThumbnailUrl": "https://img.youtube.com/vi/olB0eo_iYcA/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-01-24T10:05:00", "LastModifiedDateTime": "2025-01-24T12:18:11.633" }, { "Id": "research-33_ee0ecb8b-bb70-4780-989d-6705de1d5e06", "ContentId": "33_ee0ecb8b-bb70-4780-989d-6705de1d5e06", "Headline": "Trinity Delta - ANGLE: Adapting to align with the biggest future opportunities", "Synopsis": "ANGLE has proactively refocused the Parsortix commercial strategy to prioritise large pharma deals within the Pharma Services business. This follows growing momentum in 2024, with three large pharma deals signed that are progressing well. This business has the potential to drive significant mid- and longer-term revenues through later-stage development as part of existing deals (depth), cross-selling (breadth), and new deals (halo). The shift avoids regulatory and research funding headwinds which will likely constrain near-term revenues in the Products business. Internal resources are being appropriately deployed to Pharma Services, and streamlined in Products, whilst the building blocks remain in place to expand the Products business as conditions improve. Our DCF-based valuation is £155m, or 48p/share.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/angle-adapting-to-align-with-the-biggest-future-opportunities/33_ee0ecb8b-bb70-4780-989d-6705de1d5e06?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ae21bb63-22c4-4021-9a2f-1eba5a64697a-medical-equipment-services-4-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2025-01-23T13:49:21.547", "LastModifiedDateTime": "2025-01-23T13:49:21.513" }, { "Id": "media-22899", "ContentId": "22899", "Headline": "Proactive - ANGLE PLC’s new approach to Cancer diagnostics with Parsortix - One2One Investor Forum", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/22899", "ThumbnailUrl": "https://img.youtube.com/vi/b8lyXw--oVo/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2024-10-29T08:09:00", "LastModifiedDateTime": "2024-10-29T10:07:28.317" }, { "Id": "research-33_43c7a7ad-739a-42ed-99b3-89670d9bfc6b", "ContentId": "33_43c7a7ad-739a-42ed-99b3-89670d9bfc6b", "Headline": "Trinity Delta Lighthouse: ANGLE", "Synopsis": "Trinity Delta view: All the building blocks remain in place at ANGLE to deliver sustainable long-term growth from both Products and Services. However, in the near-term, resources will be appropriately focused on maximising the Pharma Services opportunity to capitalise on the recent momentum in this business. As and when conditions improve in the Products business, ANGLE is prepared and has the elements in place to re-invigorate this revenue stream. Whilst the slowdown in Products will impact near-term revenues, the Pharma Services focused strategy, particularly on large pharma, is an attractive mid-term opportunity. The Pharma Services sales cycle can be protracted for new customers; however, the prospect of broader relationships with existing clients could be swifter. Our valuation and forecasts remain suspended; for reference our last published ANGLE valuation was £174m, or 67p/share. .", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/trinity-delta-lighthouse-angle/33_43c7a7ad-739a-42ed-99b3-89670d9bfc6b?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/158fe0c8-21a5-4739-9ea5-1180902cbdbd-medical-equipment-services-5-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2024-10-01T07:29:41.117", "LastModifiedDateTime": "2024-10-01T07:29:41.07" }, { "Id": "research-33_59447496-d0c7-4644-9ee5-5a20323f82d4", "ContentId": "33_59447496-d0c7-4644-9ee5-5a20323f82d4", "Headline": "Trinity Delta Lighthouse: ANGLE", "Synopsis": "Trinity Delta view: ANGLE’s start to 2024 has been positive, with the execution of important new Pharma Services contracts with large pharma and securing c £8.8m (gross) in new funding to help widen the adoption of the Parsortix system. The new funds will be directed towards further building the products and service business lines, increasing headcount, and capex to augment laboratory capabilities for molecular applications. These initiatives should help build on the commercial momentum seen in FY23, with management confidence in delivering further revenue growth in FY24 and with cashflow break-even in sight. We suspend our valuation pending the closing of the fundraise; for reference our last published ANGLE valuation was £174m, or 67p/share.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/trinity-delta-lighthouse-angle/33_59447496-d0c7-4644-9ee5-5a20323f82d4?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/158fe0c8-21a5-4739-9ea5-1180902cbdbd-medical-equipment-services-5-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2024-06-06T09:49:11.313", "LastModifiedDateTime": "2024-06-06T09:49:11.297" }, { "Id": "research-33_a9920593-dc76-471c-888f-74b9f1a7f579", "ContentId": "33_a9920593-dc76-471c-888f-74b9f1a7f579", "Headline": "Trinity Delta - ANGLE: Gathering momentum in Pharma Services", "Synopsis": "Three new Pharma Services agreements with large cap pharma in 2024 demonstrate that ANGLE’s business development activities are successfully translating into customer income. These deals will make a valuable contribution to near-term revenues and also have the potential for more sizeable future revenues. Successful development of the underlying Parsortix-based assays could mean a transition into longer-term contracts for larger later-stage clinical studies, perhaps ultimately becoming companion diagnostics for commercial cancer drugs. Furthermore, the external validation provided by large cap pharma partners could facilitate future business development. Equally importantly, the resulting assays will augment ANGLE’s menu that it can offer other customers. ‘Content’ development should support both the products and services business lines, which along with clinical data generated with Parsortix to demonstrate utility in patient management, should help drive adoption. Our DCF-based valuation of ANGLE is £174m, or 67p/share.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/angle-gathering-momentum-in-pharma-services/33_a9920593-dc76-471c-888f-74b9f1a7f579?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/76271257-b7ad-42c7-b4b4-f8ee4d725a4f-medical-equipment-services-3-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2024-05-14T10:07:57.553", "LastModifiedDateTime": "2024-05-14T10:07:57.537" }, { "Id": "media-20751", "ContentId": "20751", "Headline": "Proactive - ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/20751", "ThumbnailUrl": "https://img.youtube.com/vi/wH3DUBGjJdI/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2024-05-03T11:51:00", "LastModifiedDateTime": "2024-05-03T12:07:05.317" }, { "Id": "media-20681", "ContentId": "20681", "Headline": "Proactive - ANGLE partners with AstraZeneca in groundbreaking oncology contract", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/20681", "ThumbnailUrl": "https://img.youtube.com/vi/TPvD_nmu4W8/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2024-04-24T11:15:00", "LastModifiedDateTime": "2024-04-24T12:08:39.017" }, { "Id": "media-20660", "ContentId": "20660", "Headline": "Proactive - ANGLE achieves breakthrough with EU patent for CellKeep technology, with the US to follow", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/20660", "ThumbnailUrl": "https://img.youtube.com/vi/hxu_XmeIpDA/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2024-04-22T11:28:00", "LastModifiedDateTime": "2024-04-22T12:08:57.253" }, { "Id": "research-33_7e9fb009-bf9b-4c41-9833-71d48d05eea1", "ContentId": "33_7e9fb009-bf9b-4c41-9833-71d48d05eea1", "Headline": "Trinity Delta - ANGLE: Building content to drive widespread adoption", "Synopsis": "ANGLE’s investment case rests on where Parsortix’s position in mainstream cancer diagnostics eventually lands. The place of liquid biopsies is now established and, increasingly, the additional clinical value that CTC (circulating tumour cells) assays bring is becoming clear. Addressing the many, varied opportunities directly is challenging and time consuming, with numerous barriers to overcome. Management is creating industry awareness through its demonstration and acceleration activities, which should drive near- and medium-term revenues. Similarly, a progressively robust bank of clinical data across multiple common tumours is building credibility. We view the ability to perform ctDNA and CTC DNA analysis concurrently, from a single blood draw, on third-party NGS and PCR platforms as providing a major driver for adoption. Our updated valuation is £174m, equivalent to 67p per share.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/angle-building-content-to-drive-widespread-adoption/33_7e9fb009-bf9b-4c41-9833-71d48d05eea1?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ae21bb63-22c4-4021-9a2f-1eba5a64697a-medical-equipment-services-4-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2024-01-30T07:24:49.747", "LastModifiedDateTime": "2024-01-30T07:24:49.73" }, { "Id": "media-19791", "ContentId": "19791", "Headline": "ANGLE PLC present at the Proactive One2One Investor Conference - January 11th", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/19791", "ThumbnailUrl": "https://img.youtube.com/vi/IV9VdZoaL9o/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2024-01-17T12:25:00", "LastModifiedDateTime": "2024-01-17T13:04:01.947" }, { "Id": "research-13_8a5069f5-f47b-4043-8607-198542e4a64c", "ContentId": "13_8a5069f5-f47b-4043-8607-198542e4a64c", "Headline": "Hardman & Co Healthcare Index: 2023 – Capital demands dent performance", "Synopsis": "The Hardman & Co Healthcare Index (HHI) has been running since 2009. Its main function is to highlight the attractions of life sciences investments over the long term. For the second year running, apart from global economic influences affecting world markets, performance in 2023 was dented by the capital-intensive nature of the sector. The HHI fell 3.7%, to 483.8, underperforming the main London markets – FTSE 100 (+3.8%) and FTSE All-Share (3.8%) but outperforming the FTSE AIM All-Share Index (-8.2%). Only 15 companies in our index saw share prices rise in 2023, four of these benefiting from trade sales. Despite challenges in raising new capital from the market, 15 companies (29%) did achieve successful outcomes. A number of companies are short of cash and will need more capital in order to get auditors to sign off their accounts – so 2024 looks as though it will be busy again.", "ProviderName": "Hardman & Co", "Url": "https://www.research-tree.com/research/referral/hardman-co/hardman-co-healthcare-index-2023-capital-demands-dent-performance/13_8a5069f5-f47b-4043-8607-198542e4a64c?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/dfc4b5ba-a8a8-41e6-b1a6-1e372c0ca6ab-ticker-tape-on-building-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/hardman&co logo web only.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "10X Genomics Inc", "CompanyUrl": "https://www.research-tree.com/companies/usa/health/10x-genomics-inc/TXG/NYSE", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "0f249b79-e558-4660-b07f-7abd136de9a2", "InternalId": "39e2affc-acdb-4f76-b219-5dbf2c44c485", "Isin": "US88025U1097", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "TXG:NYSE", "TIDM": "TXG", "BBTicker": "TXG", "AltTicker": "TXG", "AltExchange": "US", "Exchange": "NYSE", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 0, "TotalResearchCount": 9, "TotalRnsCount": 0 }, { "CompanyName": "Indivior Pharmaceuticals, Inc.", "CompanyUrl": "https://www.research-tree.com/companies/mexico/health/indivior-pharmaceuticals-inc-/INDV1/MEX", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "C924QD-R", "InternalId": "ef672ec5-d4e3-4642-8f1a-0c4b17c18cef", "Isin": "C924QD-R ", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Pharmaceuticals", "Ticker": "INDV1:MEX", "TIDM": "INDV1", "BBTicker": "INDV1*", "AltTicker": "INDV1*", "AltExchange": "MM", "Exchange": "MEX", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 0, "TotalResearchCount": 3, "TotalRnsCount": 1349 }, { "CompanyName": "1895 Bancorp of Wisconsin Inc", "CompanyUrl": "https://www.research-tree.com/companies/usa/banks/1895-bancorp-of-wisconsin-inc/BCOW/NYSE", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "d971c17f-9d0e-48a7-abbc-90f7faf1bc0c", "InternalId": "9991eb78-30bc-40b5-a075-5ee0131529bc", "Isin": "US28252W1053", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Banks", "Ticker": "BCOW:NYSE", "TIDM": "BCOW", "BBTicker": "BCOW", "AltTicker": "BCOW", "AltExchange": "US", "Exchange": "NYSE", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 0, "TotalResearchCount": 3, "TotalRnsCount": 0 }, { "CompanyName": "029 Group SE", "CompanyUrl": "https://www.research-tree.com/companies/germany/technology/029-group-se/Z29/ETR", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "DE000A2LQ2D0", "InternalId": "50574aea-3899-4c9b-a74c-c2a125b201e0", "Isin": "DE000A2LQ2D0", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "IT services", "Ticker": "Z29:ETR", "TIDM": "Z29", "BBTicker": "Z29", "AltTicker": "Z29", "AltExchange": "GR", "Exchange": "ETR", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 0, "TotalResearchCount": 9, "TotalRnsCount": 35 }, { "CompanyName": "10x Genomics Inc Class A", "CompanyUrl": "https://www.research-tree.com/companies/usa/health/10x-genomics-inc-class-a/TXG/NAS", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "FCDQV8-R", "InternalId": "40b7d66c-f443-4df0-8649-3173395036b8", "Isin": "FCDQV8-R ", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Biotechnology", "Ticker": "TXG:NAS", "TIDM": "TXG", "BBTicker": "TXG", "AltTicker": "TXG", "AltExchange": "US", "Exchange": "NAS", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 0, "TotalResearchCount": 9, "TotalRnsCount": 0 }, { "CompanyName": "Novacyt SAS", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/novacyt-sas/NCYT/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "FR0010397232", "InternalId": "65fbd8fc-22f7-41a2-aa20-6b1d65c744aa", "Isin": "FR0010397232", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "NCYT:LON", "TIDM": "NCYT", "BBTicker": "NCYT", "AltTicker": "NCYT", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 2, "TotalMediaCount": 4, "TotalResearchCount": 4, "TotalRnsCount": 510 }, { "CompanyName": "Genus plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/food-production/genus-plc/GNS/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0002074580", "InternalId": "0cf4a527-5a1e-4084-9c60-8e7775aa5353", "Isin": "GB0002074580", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Agriculture & Fishing", "Ticker": "GNS:LON", "TIDM": "GNS", "BBTicker": "GNS", "AltTicker": "GNS", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 6, "TotalEventCount": 3, "TotalMediaCount": 3, "TotalResearchCount": 3, "TotalRnsCount": 380 }, { "CompanyName": "Surgical Innovations Group plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/surgical-innovations-group-plc/SUN/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0004016704", "InternalId": "d3323ad9-4adf-455d-bcd1-c1087d3b71a6", "Isin": "GB0004016704", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "SUN:LON", "TIDM": "SUN", "BBTicker": "SUN", "AltTicker": "SUN", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 5, "TotalEventCount": 0, "TotalMediaCount": 0, "TotalResearchCount": 3, "TotalRnsCount": 198 }, { "CompanyName": "Advanced Medical Solutions Group plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/advanced-medical-solutions-group-plc/AMS/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0004536594", "InternalId": "715ea528-dbb7-403a-a5c1-52f4c34dfbae", "Isin": "GB0004536594", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "AMS:LON", "TIDM": "AMS", "BBTicker": "AMS", "AltTicker": "AMS", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 11, "TotalEventCount": 0, "TotalMediaCount": 3, "TotalResearchCount": 4, "TotalRnsCount": 383 }, { "CompanyName": "Oxford Metrics PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/industrial-equipment-goods-services/oxford-metrics-plc/OMG/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0030312788", "InternalId": "d4cb145b-c63d-4783-8f9a-c1b963b29ac9", "Isin": "GB0030312788", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Electrical and Electronic Equipment", "Ticker": "OMG:LON", "TIDM": "OMG", "BBTicker": "OMG", "AltTicker": "OMG", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 0, "TotalMediaCount": 6, "TotalResearchCount": 25, "TotalRnsCount": 549 }, { "CompanyName": "EKF Diagnostics Holdings plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/ekf-diagnostics-holdings-plc/EKF/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0031509804", "InternalId": "c3c864d8-7642-4572-a01d-4c6334c1966f", "Isin": "GB0031509804", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "EKF:LON", "TIDM": "EKF", "BBTicker": "EKF", "AltTicker": "EKF", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 12, "TotalEventCount": 0, "TotalMediaCount": 6, "TotalResearchCount": 3, "TotalRnsCount": 417 }, { "CompanyName": "Eco Animal Health Group PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/eco-animal-health-group-plc/EAH/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0032036807", "InternalId": "6e2e8864-32ed-4899-8e16-c44fdeea1be9", "Isin": "GB0032036807", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Pharmaceuticals", "Ticker": "EAH:LON", "TIDM": "EAH", "BBTicker": "EAH", "AltTicker": "EAH", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 8, "TotalEventCount": 9, "TotalMediaCount": 18, "TotalResearchCount": 33, "TotalRnsCount": 194 }, { "CompanyName": "ImmuPharma plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/immupharma-plc/IMM/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0033711010", "InternalId": "54fa7902-77de-474c-ab9d-fdb510e0bb2a", "Isin": "GB0033711010", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Pharmaceuticals", "Ticker": "IMM:LON", "TIDM": "IMM", "BBTicker": "IMM", "AltTicker": "IMM", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 0, "TotalMediaCount": 31, "TotalResearchCount": 8, "TotalRnsCount": 371 }, { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Allergy Therapeutics plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/allergy-therapeutics-plc/AGY/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB00B02LCQ05", "InternalId": "332e34b6-6705-4ff9-973b-1357c93950df", "Isin": "GB00B02LCQ05", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Pharmaceuticals", "Ticker": "AGY:LON", "TIDM": "AGY", "BBTicker": "AGY", "AltTicker": "AGY", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 24, "TotalEventCount": 6, "TotalMediaCount": 16, "TotalResearchCount": 219, "TotalRnsCount": 341 }, { "CompanyName": "Tristel Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/tristel-plc/TSTL/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB00B07RVT99", "InternalId": "b2f53ecd-46f3-4787-8e04-4187b3526734", "Isin": "GB00B07RVT99", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "TSTL:LON", "TIDM": "TSTL", "BBTicker": "TSTL", "AltTicker": "TSTL", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 8, "TotalEventCount": 5, "TotalMediaCount": 2, "TotalResearchCount": 115, "TotalRnsCount": 370 }, { "CompanyName": "IP Group plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/other/ip-group-plc/IPO/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB00B128J450", "InternalId": "70759bbc-2b31-4bdc-b779-6d7ae8920af1", "Isin": "GB00B128J450", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Other", "Ticker": "IPO:LON", "TIDM": "IPO", "BBTicker": "IPO", "AltTicker": "IPO", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 5, "TotalMediaCount": 23, "TotalResearchCount": 30, "TotalRnsCount": 1076 }, { "CompanyName": "Genedrive Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/genedrive-plc/GDR/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB00B1VKB244", "InternalId": "bf6fc6e8-4d5c-48a1-a47d-fe3579eb3b0b", "Isin": "GB00B1VKB244", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "GDR:LON", "TIDM": "GDR", "BBTicker": "GDR", "AltTicker": "GDR", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 8, "TotalEventCount": 0, "TotalMediaCount": 8, "TotalResearchCount": 47, "TotalRnsCount": 632 }, { "CompanyName": "hVIVO plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/other/hvivo-plc/HVO/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB00B9275X97", "InternalId": "7448d974-7569-473d-b2da-14edce283089", "Isin": "GB00B9275X97", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Other", "Ticker": "HVO:LON", "TIDM": "HVO", "BBTicker": "HVO", "AltTicker": "HVO", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 4, "TotalEventCount": 7, "TotalMediaCount": 137, "TotalResearchCount": 160, "TotalRnsCount": 635 }, { "CompanyName": "ConvaTec Group Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/convatec-group-plc/CTEC/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB00BD3VFW73", "InternalId": "87c5a677-f315-43a2-9268-3d77f1945f13", "Isin": "GB00BD3VFW73", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CTEC:LON", "TIDM": "CTEC", "BBTicker": "CTEC", "AltTicker": "CTEC", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 1, "TotalMediaCount": 2, "TotalResearchCount": 14, "TotalRnsCount": 440 }, { "CompanyName": "Oxford BioMedica plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/oxford-biomedica-plc/OXB/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB00BDFBVT43", "InternalId": "0e48282e-410b-4185-8905-9d071f02c1f4", "Isin": "GB00BDFBVT43", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Biotechnology", "Ticker": "OXB:LON", "TIDM": "OXB", "BBTicker": "OXB", "AltTicker": "OXB", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 18, "TotalEventCount": 5, "TotalMediaCount": 7, "TotalResearchCount": 63, "TotalRnsCount": 496 }, { "CompanyName": "Venture Life Group Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/venture-life-group-plc/VLG/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB00BFPM8908", "InternalId": "ffc8e8b0-8d05-464e-a9cd-9ebc41cad5e8", "Isin": "GB00BFPM8908", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Pharmaceuticals", "Ticker": "VLG:LON", "TIDM": "VLG", "BBTicker": "VLG", "AltTicker": "VLG", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 11, "TotalEventCount": 2, "TotalMediaCount": 23, "TotalResearchCount": 82, "TotalRnsCount": 384 }, { "CompanyName": "IXICO Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/other/ixico-plc/IXI/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB00BFXR4C20", "InternalId": "84c06de6-d785-4066-9afe-e27c4954e0fc", "Isin": "GB00BFXR4C20", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Other", "Ticker": "IXI:LON", "TIDM": "IXI", "BBTicker": "IXI", "AltTicker": "IXI", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 1, "TotalMediaCount": 49, "TotalResearchCount": 91, "TotalRnsCount": 362 }, { "CompanyName": "ValiRx PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/valirx-plc/VAL/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB00BLH13C52", "InternalId": "9745fcb7-3a3b-4f5e-b7c0-b8a104e4bc06", "Isin": "GB00BLH13C52", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Pharmaceuticals", "Ticker": "VAL:LON", "TIDM": "VAL", "BBTicker": "VAL", "AltTicker": "VAL", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 9, "TotalEventCount": 0, "TotalMediaCount": 61, "TotalResearchCount": 37, "TotalRnsCount": 508 }, { "CompanyName": "Avacta Group PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/other/avacta-group-plc/AVCT/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB00BYYW9G87", "InternalId": "4f149e4b-bf20-457f-8f44-62d551ea3262", "Isin": "GB00BYYW9G87", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Other", "Ticker": "AVCT:LON", "TIDM": "AVCT", "BBTicker": "AVCT", "AltTicker": "AVCT", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 14, "TotalEventCount": 0, "TotalMediaCount": 31, "TotalResearchCount": 143, "TotalRnsCount": 597 }, { "CompanyName": "123fahrschule SE", "CompanyUrl": "https://www.research-tree.com/companies/germany/leisure-tourism-travel/123fahrschule-se/123F/ETR", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "LRZFXZ-R", "InternalId": "e1a97f31-4a54-4768-b5f2-115683822e96", "Isin": "DE000A2P4HL9", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Hotels", "Ticker": "123F:ETR", "TIDM": "123F", "BBTicker": "123F", "AltTicker": "123F", "AltExchange": "GR", "Exchange": "ETR", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 0, "TotalResearchCount": 27, "TotalRnsCount": 49 }, { "CompanyName": "Immunocore Holdings Plc Shs Sponsored American Depositary Shares Repr 1 Sh", "CompanyUrl": "https://www.research-tree.com/companies/usa/health/immunocore-holdings-plc-shs-sponsored-american-depositary-shares-repr-1-sh/IMCR/NAS", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "RVT9VY-R", "InternalId": "9f320dd7-ad11-4fa8-a7d1-151ea92ec23d", "Isin": "RVT9VY-R ", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Biotechnology", "Ticker": "IMCR:NAS", "TIDM": "IMCR", "BBTicker": "IMCR", "AltTicker": "IMCR", "AltExchange": "US", "Exchange": "NAS", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 0, "TotalResearchCount": 4, "TotalRnsCount": 0 }, { "CompanyName": "Deltex Medical Group plc", "CompanyUrl": "https://www.research-tree.com/companies/usa/health/deltex-medical-group-plc/DTXMF/OTC", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "TXXQYQ-R", "InternalId": "093a2c5f-7617-4abc-b116-a0a8c09ea9cb", "Isin": "GB0059337583", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "DTXMF:OTC", "TIDM": "DTXMF", "BBTicker": "DTXMF", "AltTicker": "DTXMF", "AltExchange": "US", "Exchange": "OTC", "TotalBlogCount": 7, "TotalEventCount": 0, "TotalMediaCount": 1, "TotalResearchCount": 8, "TotalRnsCount": 212 }, { "CompanyName": "1895 Bancorp of Wisconsin Inc", "CompanyUrl": "https://www.research-tree.com/companies/usa/banks/1895-bancorp-of-wisconsin-inc/BCOW/OTC", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "US28252W1053", "InternalId": "3c7d2b0a-48dd-489c-acf8-e823906218f3", "Isin": "C63TJP-R ", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Banks", "Ticker": "BCOW:OTC", "TIDM": "BCOW", "BBTicker": "BCOW", "AltTicker": "BCOW", "AltExchange": "US", "Exchange": "OTC", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 0, "TotalResearchCount": 3, "TotalRnsCount": 0 }, { "CompanyName": "Tissue Regenix Group plc", "CompanyUrl": "https://www.research-tree.com/companies/germany/health/tissue-regenix-group-plc/LSW/STU", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "V1FMMX-R", "InternalId": "5e9bd50b-9482-496c-ac20-b588c0ee5b67", "Isin": "GB00BNTXR104", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "LSW:STU", "TIDM": "LSW", "BBTicker": "LSW", "AltTicker": "LSW", "AltExchange": "GR", "Exchange": "STU", "TotalBlogCount": 8, "TotalEventCount": 0, "TotalMediaCount": 8, "TotalResearchCount": 117, "TotalRnsCount": 349 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2024-01-12T15:44:32.467", "LastModifiedDateTime": "2024-01-12T15:44:32.45" }, { "Id": "media-19716", "ContentId": "19716", "Headline": "Proactive - ANGLE CEO says latest cancer results \"may turn out to be groundbreaking\"", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/19716", "ThumbnailUrl": "https://img.youtube.com/vi/yse17sDbDF8/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2024-01-04T12:20:00", "LastModifiedDateTime": "2024-01-04T13:08:34.31" }, { "Id": "media-19795", "ContentId": "19795", "Headline": "Vox Markets - ANGLE enters into a contract with Eisai Inc., a global pharmaceutical company, for a pilot study valued at US $250,000.", "Synopsis": "", "ProviderName": "Vox Markets", "Url": "https://www.research-tree.com/media/referrer/19795", "ThumbnailUrl": "https://d3ev5earl6dvd0.cloudfront.net/public-media/videos/006/811/006811/000002/thumb_006233.png", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/usa/health/cellbxhealth-plc/ANPCF/OTC", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "RB2CWP-R", "InternalId": "6d210533-1456-4479-b693-476cbaf21b21", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "ANPCF:OTC", "TIDM": "ANPCF", "BBTicker": "ANPCF", "AltTicker": "ANPCF", "AltExchange": "US", "Exchange": "OTC", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 1, "TotalResearchCount": 0, "TotalRnsCount": 0 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2024-01-03T15:23:59", "LastModifiedDateTime": "2024-01-17T15:03:41.08" }, { "Id": "research-33_1a89cf9d-8fc7-4eb7-a015-fc4eaeade2bc", "ContentId": "33_1a89cf9d-8fc7-4eb7-a015-fc4eaeade2bc", "Headline": "Trinity Delta Lighthouse: ANGLE", "Synopsis": "Trinity Delta view: Commercialisation of the Parsortix system is still at an early stage, although momentum is building, and management are continuing to focus on developing the potentially sizeable revenue streams through both ANGLE’s Product and Service offerings. The reality of current market conditions has driven difficult decisions to streamline infrastructure while still enabling investment into developing protocols on third-party molecular systems, and into products and services relevant to customers. We continue to believe that realising the significant commercial potential of Parsortix requires several elements to drive adoption, including developing “content” (menus of assays using CTCs harvested by Parsortix) to support both the products and services businesses, and generating clinical data with Parsortix to demonstrate utility in patient management. Following the trading and business update, we suspend our valuation and forecasts, and intend to update these as soon as practicable.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/trinity-delta-lighthouse-angle/33_1a89cf9d-8fc7-4eb7-a015-fc4eaeade2bc?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/158fe0c8-21a5-4739-9ea5-1180902cbdbd-medical-equipment-services-5-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2023-11-10T08:23:36.427", "LastModifiedDateTime": "2023-11-10T08:23:36.397" }, { "Id": "research-33_994b95db-2c2a-4cb5-b1ed-5991483643b1", "ContentId": "33_994b95db-2c2a-4cb5-b1ed-5991483643b1", "Headline": "Trinity Delta Lighthouse: ANGLE", "Synopsis": "Trinity Delta view: Recent commercial related activities, with a new pharma services contract, plus an assay development partnership, are encouraging steps towards securing potentially significant future Parsortix revenues. Both provide important external validation of Parsortix, and as this continues to build, future deal execution should be facilitated, in our view. The opportunities being explored are sizeable and will also help to expand near-term revenues. Positive revenue momentum is already evident in Q123, according to management. In the near-term, we expect ANGLE to remain focused on growing the Pharma services business, attracting industry partners for downstream analysis, and completing the remaining LDT development work ahead of potential launches from 2024. Our DCF-based ANGLE valuation is £253m, equivalent to 97p per share.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/trinity-delta-lighthouse-angle/33_994b95db-2c2a-4cb5-b1ed-5991483643b1?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/7f97e0ca-09a8-4bfa-8b3f-5448a65a8acb-medical-equipment-services-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2023-04-21T09:47:46.097", "LastModifiedDateTime": "2023-04-21T09:47:46.083" }, { "Id": "research-33_989286fa-035e-4d0e-af0e-91a155ee3d46", "ContentId": "33_989286fa-035e-4d0e-af0e-91a155ee3d46", "Headline": "Trinity Delta - ANGLE: Pursuing a multi-faceted Parsortix commercial opportunity", "Synopsis": "ANGLE successfully navigated a number of regulatory and clinical hurdles during 2022, including breakthrough FDA product clearance for Parsortix, and highly positive ovarian cancer data. Key elements are now largely in place to help deliver on Parsortix’s significant potential within the evolving liquid biopsy field. To realise this, ANGLE is pursuing a multi-pronged strategy to make Parsortix broadly available to industry and patients. The near-term focus is on growing the Pharma services business, attracting industry partnerships for downstream analysis, and completion of the remaining LDT development work. Any one of these could be transformational if successfully executed, and together should lead to multiple layers of future revenue growth. Our updated DCF-based valuation is £253m, equivalent to 97p per share.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/angle-pursuing-a-multi-faceted-parsortix-commercial-opportunity/33_989286fa-035e-4d0e-af0e-91a155ee3d46?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/7f97e0ca-09a8-4bfa-8b3f-5448a65a8acb-medical-equipment-services-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2023-03-13T08:51:59.32", "LastModifiedDateTime": "2023-03-13T08:51:59.303" }, { "Id": "research-33_e3bdb0a2-c4ae-48c3-bc5b-3d35fd152a71", "ContentId": "33_e3bdb0a2-c4ae-48c3-bc5b-3d35fd152a71", "Headline": "Trinity Delta Lighthouse: ANGLE", "Synopsis": "Trinity Delta view: Despite significant progress during 2022, including the FDA clearance of Parsortix and the highly positive ovarian cancer data, broader market headwinds dictate a more cautious stance into 2023. These challenging conditions have led to increased focus on cost control at ANGLE’s potential partners and customers, causing delays in commercial uptake. Consequently, revenues are unlikely to accelerate as rapidly as previously anticipated. Regardless of these external factors, ANGLE remains confident in its commercial strategy to make Parsortix broadly available to industry and patients, which is focused on three key areas: pharma services, corporate partnerships, and a product-led business (either directly or via distributors). We suspend our valuation and forecasts for ANGLE pending a review of our financial model.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/trinity-delta-lighthouse-angle/33_e3bdb0a2-c4ae-48c3-bc5b-3d35fd152a71?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/7f97e0ca-09a8-4bfa-8b3f-5448a65a8acb-medical-equipment-services-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2023-01-05T07:24:48.967", "LastModifiedDateTime": "2023-01-05T07:24:48.047" }, { "Id": "research-33_978a1dda-5caa-43cf-ba5f-96902dbf4927", "ContentId": "33_978a1dda-5caa-43cf-ba5f-96902dbf4927", "Headline": "Trinity Delta Lighthouse: ANGLE", "Synopsis": "Trinity Delta view: May’s FDA clearance was a major validation of Parsortix’s utility; with numerous further studies endorsing its value as a diagnostic in multiple tumour settings. Management’s challenge is addressing these wide-ranging potential uses in a systematic, effective, and efficient manner. H122 results highlight the strategy to address a variety of distinct diagnostic segments, with both near- and longer-term objectives, is gaining momentum. The recent £18.9m equity raise removes near-term financial uncertainty. We value ANGLE at £506m ($658m), equivalent to 215p/share, with significant upside once Parsortix’s positioning becomes clearer.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/trinity-delta-lighthouse-angle/33_978a1dda-5caa-43cf-ba5f-96902dbf4927?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/4416f982-74ce-4bbf-8c59-67fbe2fa32fd-medical-equipment-services-2-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2022-09-29T13:59:13.24", "LastModifiedDateTime": "2022-09-29T13:59:10.633" }, { "Id": "research-33_09d3619e-9f64-43b1-bdb3-ae4717730c47", "ContentId": "33_09d3619e-9f64-43b1-bdb3-ae4717730c47", "Headline": "Trinity Delta Lighthouse: ANGLE", "Synopsis": "Trinity Delta view: The FDA clearance of the Parsortix system in mBC was a major turning point for ANGLE, providing gold standard validation of the unrivalled flexibility, consistency, and clinical insights it provides. The challenge now shifts to maximising industry awareness and capitalising on the multiple clinical opportunities. Management is pursuing a well-articulated strategy addressing a number of distinct diagnostic segments, with both near- and longer-term objectives. This equity raise removes financial uncertainty and allows, on our conservative forecasts, these marketing and commercialisation plans to be funded through to mid-2024. Our ANGLE valuation is £506m ($658m), which would be equivalent to 194p/share based on the increased number of shares, with significant upside once Parsortix’s positioning becomes clearer.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/trinity-delta-lighthouse-angle/33_09d3619e-9f64-43b1-bdb3-ae4717730c47?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/7f97e0ca-09a8-4bfa-8b3f-5448a65a8acb-medical-equipment-services-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2022-07-15T13:45:50.517", "LastModifiedDateTime": "2022-07-15T13:45:49.313" }, { "Id": "research-33_f14f0f5b-c227-48af-9a83-5bcb3f86ada4", "ContentId": "33_f14f0f5b-c227-48af-9a83-5bcb3f86ada4", "Headline": "Trinity Delta Lighthouse: ANGLE", "Synopsis": "Trinity Delta view: FDA clearance of the Parsortix system in mBC has been a clear focus for many investors. Achievement of this gold standard validation could transform ANGLE, with a potential near-term acceleration in revenues from the Pharma Service business, in which we see significant value. Longer-term, this could also drive revenues in mBC. We continue to believe ANGLE is well positioned to capitalise on growing recognition of the utility of CTC analysis in investigating protein markers on cancer cells, without the limitations of ctDNA (circulating tumour DNA) liquid biopsy (inapplicable to proteins) or tissue biopsies (unsuitable for longitudinal monitoring). We value ANGLE at £506m ($658m), or 215p/share with significant upside once Parsortix’s positioning becomes clearer.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/trinity-delta-lighthouse-angle/33_f14f0f5b-c227-48af-9a83-5bcb3f86ada4?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/7f97e0ca-09a8-4bfa-8b3f-5448a65a8acb-medical-equipment-services-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2022-05-26T08:08:46.583", "LastModifiedDateTime": "2022-05-26T08:08:46.52" }, { "Id": "research-33_f722b402-6f1a-4fd8-8ed0-2e0d5d22244b", "ContentId": "33_f722b402-6f1a-4fd8-8ed0-2e0d5d22244b", "Headline": "Trinity Delta Lighthouse: ANGLE", "Synopsis": "Trinity Delta view: During 2021 ANGLE laid important foundations ahead of key events that should accelerate commercial prospects. Positive momentum in pharma services contracts and corporate partnerships coupled to new assay and LDT development will contribute to top-line growth. However, potential FDA clearance of the Parsortix system in mBC is a clear focus for many investors and will provide important validation for external partners. ANGLE is well positioned to capitalise on growing recognition of the utility of CTC analysis in investigating protein markers on cancer cells, without the limitations of ctDNA (circulating tumour DNA) liquid biopsy (inapplicable to proteins) or tissue biopsies (unsuitable for longitudinal monitoring). We value ANGLE at £506m ($658m), or 215p/share.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/trinity-delta-lighthouse-angle/33_f722b402-6f1a-4fd8-8ed0-2e0d5d22244b?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/4416f982-74ce-4bbf-8c59-67fbe2fa32fd-medical-equipment-services-2-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2022-04-28T07:43:37.393", "LastModifiedDateTime": "2022-04-28T07:43:36.893" }, { "Id": "research-3d8b598e-7515-448c-8c14-dfd20c1ae427", "ContentId": "3d8b598e-7515-448c-8c14-dfd20c1ae427", "Headline": "Trinity Delta - FDA approval awaited, LDT data expected H122", "Synopsis": "ANGLE’s updates reveal dialogue with FDA for Parsortix’s approval for use in mBC (metastatic breast cancer) is continuing and constructive, first submissions for accreditation of UK and US clinical laboratories have been made, but development of the ovarian cancer LDT (Laboratory Developed Test) has been hampered by a delay to data read out from a key study (due to third-party supply issues) to H122. A new study comparing CTC harvest and downstream analysis against biopsies in mBC shows good correlation and indicates Parsortix use could materially benefit clinical diagnoses and treatments. The longer wait for FDA approval and first LDT roll-out prompt us to revisit our forecasts and valuation models. Our new valuation of £506m ($658m), or 215p/share compares to £581m ($755m), 248p/share previously.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/fda-approval-awaited-ldt-data-expected-h122/3d8b598e-7515-448c-8c14-dfd20c1ae427?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ae21bb63-22c4-4021-9a2f-1eba5a64697a-medical-equipment-services-4-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "International", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2022-01-17T00:00:00", "LastModifiedDateTime": "2022-01-18T08:53:50.633" }, { "Id": "research-8e664f01-c9ee-49f8-890e-610af44e4bc9", "ContentId": "8e664f01-c9ee-49f8-890e-610af44e4bc9", "Headline": "Trinity Delta - Poised to disrupt existing tumour assay protocols", "Synopsis": "ANGLE’s H121 results confirm progress of its proprietary Parsortix cancer diagnostic platform across multiple fronts. Whilst attention inevitably focusses on the expected upcoming FDA approval for use in metastatic breast cancer, important progress has been achieved with developing the ovarian cancer LDT (Laboratory Developed Test). UK and US clinical laboratories, created ahead of schedule, are anticipated to receive certification by year-end. This will drive nearer term revenues from pharma services, demonstrate the clinical value, and validate the proposition for larger commercial labs. Collectively these efforts will help shape Parsortix’s positioning in the emerging, and dynamic, liquid biopsy market. We value ANGLE at £581m ($755m), 248p/share.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/poised-to-disrupt-existing-tumour-assay-protocols/8e664f01-c9ee-49f8-890e-610af44e4bc9?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/158fe0c8-21a5-4739-9ea5-1180902cbdbd-medical-equipment-services-5-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "International", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-10-01T00:00:00", "LastModifiedDateTime": "2021-11-16T07:48:25.563" }, { "Id": "research-8_30951", "ContentId": "8_30951", "Headline": "Cavendish - Morning Note – 30 September 2021", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-30-september-2021/8_30951?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ca5de4b5-06e9-4de9-87a6-17f0ad24fca7-stock-market-prices-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "4basebio PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/4basebio-plc/4BB/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Pharmaceuticals & Biotechnology" ], "Id": "FQB1TH-R", "InternalId": "e61ebbbf-9a78-4360-9ebf-9b4a6d526f3c", "Isin": "GB00BMCLYF79", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Biotechnology", "Ticker": "4BB:LON", "TIDM": "4BB", "BBTicker": "4BB", "AltTicker": "4BB", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 0, "TotalResearchCount": 38, "TotalRnsCount": 136 }, { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Redcentric Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/technology/redcentric-plc/RCN/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Software & Computer Services" ], "Id": "GB00B7TW1V39", "InternalId": "1ce0da22-d48c-4f3f-ab28-85154e321c50", "Isin": "GB00B7TW1V39", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "IT services", "Ticker": "RCN:LON", "TIDM": "RCN", "BBTicker": "RCN", "AltTicker": "RCN", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 8, "TotalEventCount": 0, "TotalMediaCount": 2, "TotalResearchCount": 103, "TotalRnsCount": 467 }, { "CompanyName": "Savannah Energy Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/energy/savannah-energy-plc/SAVE/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Energy" ], "Id": "GB00BP41S218", "InternalId": "2748d776-4439-44ce-ab67-dfbcaaa7367c", "Isin": "GB00BP41S218", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Oil & Gas - Integrated", "Ticker": "SAVE:LON", "TIDM": "SAVE", "BBTicker": "SAVE", "AltTicker": "SAVE", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 1, "TotalEventCount": 0, "TotalMediaCount": 4, "TotalResearchCount": 96, "TotalRnsCount": 402 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-09-30T07:56:23.483", "LastModifiedDateTime": "2021-09-30T07:56:23.247" }, { "Id": "research-8_30691", "ContentId": "8_30691", "Headline": "Cavendish - ANGLE - Interims: FDA clearance looming, service business growing", "Synopsis": "ANGLE reported an adjusted net loss of £7.2m (+58% vs. -£3.2m), with establishment revenues increasing 26% to £0.3m and costs rising 48% to £8.9m, reflecting the costs of opening its pharma services business and clinical laboratories in the US and UK. Net cash at 30 June was £21.0m, with a further £18.9m (net) placing proceeds after period-end. Evidence of momentum building within pharma services, backed by confirmation of three contract wins and multiple ongoing discussions (some of which are w", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/cavendish/angle-interims-fda-clearance-looming-service-business-growing/8_30691?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/4416f982-74ce-4bbf-8c59-67fbe2fa32fd-medical-equipment-services-2-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-09-30T07:47:05.9", "LastModifiedDateTime": "2021-09-30T07:47:05.727" }, { "Id": "research-8_30743", "ContentId": "8_30743", "Headline": "Cavendish - Morning Note – 27 September 2021", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-27-september-2021/8_30743?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/dfc4b5ba-a8a8-41e6-b1a6-1e372c0ca6ab-ticker-tape-on-building-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "Touchstone Exploration Inc", "CompanyUrl": "https://www.research-tree.com/companies/uk/energy/touchstone-exploration-inc/TXP/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Oil & Gas" ], "Id": "CA89156L1085", "InternalId": "e95603fa-a065-4978-82eb-c4c28fa022db", "Isin": "KK2N26-R ", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Oil & Gas - E&Ps", "Ticker": "TXP:LON", "TIDM": "TXP", "BBTicker": "TXP", "AltTicker": "TXP", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 40, "TotalResearchCount": 131, "TotalRnsCount": 475 }, { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Elixirr International Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/other/elixirr-international-plc/ELIX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Business Services" ], "Id": "GB00BLPHTX84", "InternalId": "90e61e79-97f2-44ed-979e-dacad8a18d2f", "Isin": "GB00BLPHTX84", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Other", "Ticker": "ELIX:LON", "TIDM": "ELIX", "BBTicker": "ELIX", "AltTicker": "ELIX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 4, "TotalMediaCount": 1, "TotalResearchCount": 64, "TotalRnsCount": 145 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-09-27T07:37:45.713", "LastModifiedDateTime": "2021-09-27T07:37:45.563" }, { "Id": "research-8_30465", "ContentId": "8_30465", "Headline": "Cavendish - Morning Note – 20 September 2021", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-20-september-2021/8_30465?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ca5de4b5-06e9-4de9-87a6-17f0ad24fca7-stock-market-prices-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Frenkel Topping Group plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/financial-services/frenkel-topping-group-plc/FEN/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Financial Services" ], "Id": "GB00B01YXQ71", "InternalId": "98ec0abe-f5fd-4fd1-92fc-a842aef3e6ca", "Isin": "GB00B01YXQ71", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Asset Management", "Ticker": "FEN:LON", "TIDM": "FEN", "BBTicker": "FEN", "AltTicker": "FEN", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 2, "TotalEventCount": 1, "TotalMediaCount": 3, "TotalResearchCount": 79, "TotalRnsCount": 279 }, { "CompanyName": "hVIVO plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/other/hvivo-plc/HVO/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Life Sciences" ], "Id": "GB00B9275X97", "InternalId": "7448d974-7569-473d-b2da-14edce283089", "Isin": "GB00B9275X97", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Other", "Ticker": "HVO:LON", "TIDM": "HVO", "BBTicker": "HVO", "AltTicker": "HVO", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 4, "TotalEventCount": 7, "TotalMediaCount": 137, "TotalResearchCount": 160, "TotalRnsCount": 635 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-09-20T07:48:40.56", "LastModifiedDateTime": "2021-09-20T07:48:40.377" }, { "Id": "research-8_29778", "ContentId": "8_29778", "Headline": "Cavendish - Morning Note – 9 August 2021", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-9-august-2021/8_29778?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ca5de4b5-06e9-4de9-87a6-17f0ad24fca7-stock-market-prices-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "M.P. Evans Group PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/food-production/m-p-evans-group-plc/MPE/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Food Producers" ], "Id": "GB0007538100", "InternalId": "b7fa70d7-7d68-4c2e-b085-ec008a8a392a", "Isin": "GB0007538100", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Agriculture & Fishing", "Ticker": "MPE:LON", "TIDM": "MPE", "BBTicker": "MPE", "AltTicker": "MPE", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 6, "TotalEventCount": 2, "TotalMediaCount": 13, "TotalResearchCount": 129, "TotalRnsCount": 1139 }, { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "hVIVO plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/other/hvivo-plc/HVO/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Life Sciences" ], "Id": "GB00B9275X97", "InternalId": "7448d974-7569-473d-b2da-14edce283089", "Isin": "GB00B9275X97", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Other", "Ticker": "HVO:LON", "TIDM": "HVO", "BBTicker": "HVO", "AltTicker": "HVO", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 4, "TotalEventCount": 7, "TotalMediaCount": 137, "TotalResearchCount": 160, "TotalRnsCount": 635 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-08-09T07:52:27.633", "LastModifiedDateTime": "2021-08-09T07:52:27.04" }, { "Id": "media-10817", "ContentId": "10817", "Headline": "Proactive - FTSE lacks direction, US tech giants report thumping results as traders nervously await US Fed update", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/10817", "ThumbnailUrl": "https://img.youtube.com/vi/17dHJygj3uQ/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-07-28T10:06:00", "LastModifiedDateTime": "2021-07-28T10:08:59.227" }, { "Id": "research-8_29584", "ContentId": "8_29584", "Headline": "Cavendish - ANGLE - Pharma services contract with new customer", "Synopsis": "ANGLE announced its second pharma services contract with an undisclosed drug development company, using Parsortix firstly to develop two custom CTC assays to look at biomarkers of DNA damage repair, for which it will be paid c.$0.4m and, secondly, if successful, to use these validated assays for longitudinal analysis in a subsequent clinical trial planned to start in H2 2022. The revenue from the first phase of the contract is expected to be recognised over a 12-month period. ANGLE also confirme", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/cavendish/angle-pharma-services-contract-with-new-customer/8_29584?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/7f97e0ca-09a8-4bfa-8b3f-5448a65a8acb-medical-equipment-services-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-07-28T09:16:43.577", "LastModifiedDateTime": "2021-07-28T09:16:43.417" }, { "Id": "research-8_29247", "ContentId": "8_29247", "Headline": "Cavendish - Morning Note – 9 July 2021", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-9-july-2021/8_29247?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/dfc4b5ba-a8a8-41e6-b1a6-1e372c0ca6ab-ticker-tape-on-building-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "hVIVO plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/other/hvivo-plc/HVO/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Life Sciences" ], "Id": "GB00B9275X97", "InternalId": "7448d974-7569-473d-b2da-14edce283089", "Isin": "GB00B9275X97", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Other", "Ticker": "HVO:LON", "TIDM": "HVO", "BBTicker": "HVO", "AltTicker": "HVO", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 4, "TotalEventCount": 7, "TotalMediaCount": 137, "TotalResearchCount": 160, "TotalRnsCount": 635 }, { "CompanyName": "Parkmead Group PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/energy/parkmead-group-plc/PMG/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Oil & Gas" ], "Id": "GB00BGCYZL73", "InternalId": "d0efeeb4-261c-46f6-b31e-11ca4c7d75fa", "Isin": "GB00BGCYZL73", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Oil & Gas - E&Ps", "Ticker": "PMG:LON", "TIDM": "PMG", "BBTicker": "PMG", "AltTicker": "PMG", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 2, "TotalEventCount": 0, "TotalMediaCount": 1, "TotalResearchCount": 81, "TotalRnsCount": 129 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-07-09T07:37:02.287", "LastModifiedDateTime": "2021-07-09T07:37:02.103" }, { "Id": "research-3f6be952-00a0-48fe-b1de-041a4cd452f8", "ContentId": "3f6be952-00a0-48fe-b1de-041a4cd452f8", "Headline": "Trinity Delta - £20m placing to accelerate Parsortix opportunities ", "Synopsis": "ANGLE has raised £20m (gross) to maintain momentum in consolidating its position as the leading player in CTC liquid biopsy. Its proprietary Parsortix microfluidic device captures circulating tumour cells (CTCs) for analysis and can complement ctDNA (circulating tumour DNA) liquid biopsies. New monies boost pro forma cash to c £47m supporting current initiatives (eg breast and ovarian cancer), new opportunities to expand Parsortix’s utility, and expanding the commercial infrastructure. ANGLE has identified two specific, highly commercially attractive opportunities: an LDT to assess prostate cancer risk, and a PD-L1 pharma services assay for clinical trials. Both would be offered through its two clinical laboratories (UK and US), which in addition to accelerating Parsortix system adoption, also act as demonstrators of how it enables targeted treatments, response monitoring, and improved patient outcomes. Our updated DCF-based model generates a valuation of £570m ($741m), or 244p/share.", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/-20m-placing-to-accelerate-parsortix-opportunities-/3f6be952-00a0-48fe-b1de-041a4cd452f8?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/158fe0c8-21a5-4739-9ea5-1180902cbdbd-medical-equipment-services-5-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "International", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-06-28T00:00:00", "LastModifiedDateTime": "2021-11-16T07:10:33.393" }, { "Id": "research-8_28720", "ContentId": "8_28720", "Headline": "Cavendish - ANGLE - Placing raises £20m", "Synopsis": "ANGLE has raised £20m (gross) to accelerate further clinical applications for Parsortix and exploit the first-mover advantage that the FDA clearance for Parsortix will create. The funds will be used to develop a pre-biopsy test for prostate cancer, expanding its assay development capabilities for its pharma services business and strengthening management in the US to capitalise on the enormous opportunity that the adoption of liquid biopsies in this market offers. It also funds the ongoing operat", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/cavendish/angle-placing-raises-20m/8_28720?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/76271257-b7ad-42c7-b4b4-f8ee4d725a4f-medical-equipment-services-3-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-06-25T08:21:33.733", "LastModifiedDateTime": "2021-06-25T08:21:33.59" }, { "Id": "research-8_28468", "ContentId": "8_28468", "Headline": "Cavendish - Morning Note – 1 June 2021", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-1-june-2021/8_28468?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/dfc4b5ba-a8a8-41e6-b1a6-1e372c0ca6ab-ticker-tape-on-building-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "Gooch & Housego PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/discretionary-personal-goods/gooch-housego-plc/GHH/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Electronic & Electrical Equipment" ], "Id": "GB0002259116", "InternalId": "8ab95cf7-f38f-47d1-ad76-3720d62f5c85", "Isin": "GB0002259116", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Electronic Products", "Ticker": "GHH:LON", "TIDM": "GHH", "BBTicker": "GHH", "AltTicker": "GHH", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 5, "TotalEventCount": 1, "TotalMediaCount": 9, "TotalResearchCount": 170, "TotalRnsCount": 295 }, { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Savannah Energy Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/energy/savannah-energy-plc/SAVE/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Energy" ], "Id": "GB00BP41S218", "InternalId": "2748d776-4439-44ce-ab67-dfbcaaa7367c", "Isin": "GB00BP41S218", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Oil & Gas - Integrated", "Ticker": "SAVE:LON", "TIDM": "SAVE", "BBTicker": "SAVE", "AltTicker": "SAVE", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 1, "TotalEventCount": 0, "TotalMediaCount": 4, "TotalResearchCount": 96, "TotalRnsCount": 402 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-06-01T08:11:33.487", "LastModifiedDateTime": "2023-04-04T10:08:20.673" }, { "Id": "media-10283", "ContentId": "10283", "Headline": "Angle (LON:AGL) Presenting at the Proactive One2One Virtual Forum", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/10283", "ThumbnailUrl": "https://img.youtube.com/vi/oYkwyEHI-yw/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-05-21T11:29:00", "LastModifiedDateTime": "2021-05-21T11:38:27.107" }, { "Id": "research-4dc380a2-61ba-459a-816f-53d006477281", "ContentId": "4dc380a2-61ba-459a-816f-53d006477281", "Headline": "Trinity Delta - Parsortix commercial traction would be transformational ", "Synopsis": "ANGLE is progressing its proprietary Parsortix cancer diagnostic platform through several key inflection points over the next 24 months, most notably FDA approval. In parallel, it has initiated commercialisation through the creation of two clinical laboratories (in the UK and US), which can offer services to the pharma industry and LDTs (Laboratory Developed Tests) for the clinical market. Parsortix is an elegant microfluidic device that captures circulating tumour cells (CTCs) for analysis. Such liquid biopsies will be employed increasingly not only in initial diagnosis, but to monitor and guide treatment. Our DCF-based valuation is £549m, or 255p per share. ", "ProviderName": "Trinity Delta", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/trinity-delta/parsortix-commercial-traction-would-be-transformational-/4dc380a2-61ba-459a-816f-53d006477281?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/7f97e0ca-09a8-4bfa-8b3f-5448a65a8acb-medical-equipment-services-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "International", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-05-11T08:32:46.237", "LastModifiedDateTime": "2021-05-23T23:49:40.407" }, { "Id": "research-8_27869", "ContentId": "8_27869", "Headline": "Cavendish - Morning Note – 29 April 2021", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-29-april-2021/8_27869?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ca5de4b5-06e9-4de9-87a6-17f0ad24fca7-stock-market-prices-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Xeros Technology Group Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/industrial-equipment-goods-services/xeros-technology-group-plc/XSG/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Industrial Technology" ], "Id": "GB00BJFLLV84", "InternalId": "c2f03a95-74b5-4ece-87d7-8b3aa665c26b", "Isin": "GB00BMGYBJ57", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Industrials - Specialty & Parts", "Ticker": "XSG:LON", "TIDM": "XSG", "BBTicker": "XSG", "AltTicker": "XSG", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 1, "TotalEventCount": 2, "TotalMediaCount": 3, "TotalResearchCount": 70, "TotalRnsCount": 437 }, { "CompanyName": "Shield Therapeutics Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/shield-therapeutics-plc/STX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Pharmaceuticals & Biotechnology" ], "Id": "GB00BYV81293", "InternalId": "0ed19836-e7b5-4e89-9723-90101c703626", "Isin": "GB00BYV81293", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Pharmaceuticals", "Ticker": "STX:LON", "TIDM": "STX", "BBTicker": "STX", "AltTicker": "STX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 4, "TotalEventCount": 1, "TotalMediaCount": 32, "TotalResearchCount": 252, "TotalRnsCount": 421 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-04-29T07:47:21.873", "LastModifiedDateTime": "2021-07-05T12:04:06.187" }, { "Id": "research-8_27473", "ContentId": "8_27473", "Headline": "Cavendish - ANGLE - FY 2020 – progressing towards FDA clearance", "Synopsis": "ANGLE’s results to 31 December 2020 showed revenues and an adjusted net loss of £0.8m and £11.2m compared with £0.6m and £7.2m, respectively (8 months to December 2019). Year-end cash of £28.6m was c.£3m better than we expected, mainly related to timing events including fit-out costs for its recently opened clinical labs in the US and UK. The company’s confirmation that it intends to submit its responses to the FDA in May, supports our expectation of an H2 clearance, which will be a major value ", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/cavendish/angle-fy-2020-progressing-towards-fda-clearance/8_27473?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ae21bb63-22c4-4021-9a2f-1eba5a64697a-medical-equipment-services-4-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-04-29T07:18:01.77", "LastModifiedDateTime": "2021-04-29T07:18:01.727" }, { "Id": "research-8_27784", "ContentId": "8_27784", "Headline": "Cavendish - Rude Health - finnCap Life Sciences quarterly sector note", "Synopsis": "Summary: In this report we outline the investment case for three companies that we believe are primed for growth: Diurnal, Kromek and Oxford Biodynamics. We also include the outlook for the AIM healthcare sector and overall healthcare sector, industry and capital market indicators, key sector news, recent research highlights and a profile of all the companies covered by the finnCap Life Sciences team.", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/rude-health-finncap-life-sciences-quarterly-sector-note/8_27784?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/dfc4b5ba-a8a8-41e6-b1a6-1e372c0ca6ab-ticker-tape-on-building-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "4basebio PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/4basebio-plc/4BB/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Pharmaceuticals & Biotechnology" ], "Id": "FQB1TH-R", "InternalId": "e61ebbbf-9a78-4360-9ebf-9b4a6d526f3c", "Isin": "GB00BMCLYF79", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Biotechnology", "Ticker": "4BB:LON", "TIDM": "4BB", "BBTicker": "4BB", "AltTicker": "4BB", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 0, "TotalResearchCount": 38, "TotalRnsCount": 136 }, { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Allergy Therapeutics plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/allergy-therapeutics-plc/AGY/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Pharmaceuticals & Biotechnology" ], "Id": "GB00B02LCQ05", "InternalId": "332e34b6-6705-4ff9-973b-1357c93950df", "Isin": "GB00B02LCQ05", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Pharmaceuticals", "Ticker": "AGY:LON", "TIDM": "AGY", "BBTicker": "AGY", "AltTicker": "AGY", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 24, "TotalEventCount": 6, "TotalMediaCount": 16, "TotalResearchCount": 219, "TotalRnsCount": 341 }, { "CompanyName": "Tristel Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/tristel-plc/TSTL/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare Equipment & Services" ], "Id": "GB00B07RVT99", "InternalId": "b2f53ecd-46f3-4787-8e04-4187b3526734", "Isin": "GB00B07RVT99", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "TSTL:LON", "TIDM": "TSTL", "BBTicker": "TSTL", "AltTicker": "TSTL", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 8, "TotalEventCount": 5, "TotalMediaCount": 2, "TotalResearchCount": 115, "TotalRnsCount": 370 }, { "CompanyName": "Cambridge Nutritional Sciences PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cambridge-nutritional-sciences-plc/CNSL/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare Equipment & Services" ], "Id": "GB00B1VCP282", "InternalId": "4521e1cf-b329-408c-8c2f-d0c0dd4e91b6", "Isin": "GB00B1VCP282", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CNSL:LON", "TIDM": "CNSL", "BBTicker": "CNSL", "AltTicker": "CNSL", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 0, "TotalMediaCount": 4, "TotalResearchCount": 147, "TotalRnsCount": 493 }, { "CompanyName": "SDI Group plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/industrial-equipment-goods-services/sdi-group-plc/SDI/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare Equipment & Services" ], "Id": "GB00B3FBWW43", "InternalId": "faf8097e-e8b4-4f82-bfa9-60c0b393fa49", "Isin": "GB00B3FBWW43", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Electrical and Electronic Equipment", "Ticker": "SDI:LON", "TIDM": "SDI", "BBTicker": "SDI", "AltTicker": "SDI", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 9, "TotalEventCount": 2, "TotalMediaCount": 3, "TotalResearchCount": 151, "TotalRnsCount": 262 }, { "CompanyName": "Bioventix Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/bioventix-plc/BVXP/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Pharmaceuticals & Biotechnology" ], "Id": "GB00B4QVDF07", "InternalId": "1d281a6f-df0a-4cbb-a11e-d5ac19d0c8eb", "Isin": "GB00B4QVDF07", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Biotechnology", "Ticker": "BVXP:LON", "TIDM": "BVXP", "BBTicker": "BVXP", "AltTicker": "BVXP", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 10, "TotalEventCount": 6, "TotalMediaCount": 7, "TotalResearchCount": 68, "TotalRnsCount": 150 }, { "CompanyName": "Cambridge Cognition Holdings Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/technology/cambridge-cognition-holdings-plc/COG/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare Equipment & Services" ], "Id": "GB00B8DV9647", "InternalId": "ec7c9c2c-28b8-4d26-aa64-8bf78e6e455c", "Isin": "GB00B8DV9647", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Software", "Ticker": "COG:LON", "TIDM": "COG", "BBTicker": "COG", "AltTicker": "COG", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 3, "TotalEventCount": 2, "TotalMediaCount": 5, "TotalResearchCount": 21, "TotalRnsCount": 314 }, { "CompanyName": "hVIVO plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/other/hvivo-plc/HVO/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Life Sciences" ], "Id": "GB00B9275X97", "InternalId": "7448d974-7569-473d-b2da-14edce283089", "Isin": "GB00B9275X97", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Other", "Ticker": "HVO:LON", "TIDM": "HVO", "BBTicker": "HVO", "AltTicker": "HVO", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 4, "TotalEventCount": 7, "TotalMediaCount": 137, "TotalResearchCount": 160, "TotalRnsCount": 635 }, { "CompanyName": "Shield Therapeutics Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/shield-therapeutics-plc/STX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Pharmaceuticals & Biotechnology" ], "Id": "GB00BYV81293", "InternalId": "0ed19836-e7b5-4e89-9723-90101c703626", "Isin": "GB00BYV81293", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Pharmaceuticals", "Ticker": "STX:LON", "TIDM": "STX", "BBTicker": "STX", "AltTicker": "STX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 4, "TotalEventCount": 1, "TotalMediaCount": 32, "TotalResearchCount": 252, "TotalRnsCount": 421 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-04-28T07:13:06.347", "LastModifiedDateTime": "2023-08-15T17:04:22.727" }, { "Id": "research-8_27755", "ContentId": "8_27755", "Headline": "Cavendish - Morning Note – 26 April 2021", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-26-april-2021/8_27755?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/b579ca8e-bcca-466a-9b40-4c340fdc48b0-financial-ticker-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "Touchstone Exploration Inc", "CompanyUrl": "https://www.research-tree.com/companies/uk/energy/touchstone-exploration-inc/TXP/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Oil & Gas" ], "Id": "CA89156L1085", "InternalId": "e95603fa-a065-4978-82eb-c4c28fa022db", "Isin": "KK2N26-R ", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Oil & Gas - E&Ps", "Ticker": "TXP:LON", "TIDM": "TXP", "BBTicker": "TXP", "AltTicker": "TXP", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 40, "TotalResearchCount": 131, "TotalRnsCount": 475 }, { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Tristel Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/tristel-plc/TSTL/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare Equipment & Services" ], "Id": "GB00B07RVT99", "InternalId": "b2f53ecd-46f3-4787-8e04-4187b3526734", "Isin": "GB00B07RVT99", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "TSTL:LON", "TIDM": "TSTL", "BBTicker": "TSTL", "AltTicker": "TSTL", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 8, "TotalEventCount": 5, "TotalMediaCount": 2, "TotalResearchCount": 115, "TotalRnsCount": 370 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-04-26T07:52:40.027", "LastModifiedDateTime": "2021-04-26T07:52:39.807" }, { "Id": "media-9970", "ContentId": "9970", "Headline": "Proactive - ANGLE announce first large-scale pharma services contract for Parsortix liquid biopsy", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/9970", "ThumbnailUrl": "https://img.youtube.com/vi/qyIHJuI8n_g/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-04-16T12:34:00", "LastModifiedDateTime": "2021-04-19T09:58:34.797" }, { "Id": "research-8_27495", "ContentId": "8_27495", "Headline": "Cavendish - Morning Note – 16 April 2021", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-16-april-2021/8_27495?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ca5de4b5-06e9-4de9-87a6-17f0ad24fca7-stock-market-prices-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-04-16T07:39:43.983", "LastModifiedDateTime": "2021-04-16T07:39:43.793" }, { "Id": "research-8_27119", "ContentId": "8_27119", "Headline": "Cavendish - Morning Note – 30 March 2021", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-30-march-2021/8_27119?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/dfc4b5ba-a8a8-41e6-b1a6-1e372c0ca6ab-ticker-tape-on-building-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Pulsar Group PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/technology/pulsar-group-plc/PULS/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Software & Computer Services" ], "Id": "GB00BGQVB052", "InternalId": "8a8a51db-1591-44ac-ae40-6ae76ef2f6e9", "Isin": "GB00BGQVB052", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Software", "Ticker": "PULS:LON", "TIDM": "PULS", "BBTicker": "PULS", "AltTicker": "PULS", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 5, "TotalResearchCount": 77, "TotalRnsCount": 247 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-03-30T07:46:16.26", "LastModifiedDateTime": "2021-03-30T11:53:06.7" }, { "Id": "research-8_26567", "ContentId": "8_26567", "Headline": "Cavendish - Morning Note – 4 March 2021", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-4-march-2021/8_26567?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/b579ca8e-bcca-466a-9b40-4c340fdc48b0-financial-ticker-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-03-04T07:45:56.597", "LastModifiedDateTime": "2024-11-08T12:42:31.023" }, { "Id": "research-8_26266", "ContentId": "8_26266", "Headline": "Cavendish - Morning Note – 18 February 2021", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-18-february-2021/8_26266?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/b579ca8e-bcca-466a-9b40-4c340fdc48b0-financial-ticker-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "Trifast plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/resources/trifast-plc/TRI/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Industrial Engineering" ], "Id": "GB0008883927", "InternalId": "25e0668b-b1a1-45a5-af12-82fa505ab33e", "Isin": "GB0008883927", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Industrial Metals - Iron & Steel", "Ticker": "TRI:LON", "TIDM": "TRI", "BBTicker": "TRI", "AltTicker": "TRI", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 16, "TotalEventCount": 0, "TotalMediaCount": 21, "TotalResearchCount": 161, "TotalRnsCount": 362 }, { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "International", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-02-18T07:36:43.267", "LastModifiedDateTime": "2021-02-18T09:42:29.15" }, { "Id": "research-8_26001", "ContentId": "8_26001", "Headline": "Cavendish - ANGLE - Peer-reviewed publication highlights Parsortix in NSCLC", "Synopsis": "The 40th independent peer-reviewed publication, in this case using Parsortix to monitor changes in CTC gene expression in non-small cell lung cancer (NSCLC) patients with an EGFR mutation being treated with AstraZeneca’s Tagrisso, offers further evidence of the utility (patient selection and disease monitoring) of Parsortix beyond the immediate clinical indications that ANGLE is pursuing (breast and ovarian cancers). Given the incidence of NSCLC, the poor survival rates and the need for improved", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/cavendish/angle-peer-reviewed-publication-highlights-parsortix-in-nsclc/8_26001?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/158fe0c8-21a5-4739-9ea5-1180902cbdbd-medical-equipment-services-5-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "International", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-02-08T09:01:48.493", "LastModifiedDateTime": "2021-02-08T10:27:48.57" }, { "Id": "research-8_25772", "ContentId": "8_25772", "Headline": "Cavendish - Morning Note – 29 January 2021", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-29-january-2021/8_25772?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/b579ca8e-bcca-466a-9b40-4c340fdc48b0-financial-ticker-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "International", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-01-29T07:36:33.89", "LastModifiedDateTime": "2021-01-29T08:05:29.987" }, { "Id": "media-9353", "ContentId": "9353", "Headline": "ANGLE present at the Proactive One2One live virtual conference", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/9353", "ThumbnailUrl": "https://img.youtube.com/vi/5gx3zy9iJes/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2021-01-22T00:00:00", "LastModifiedDateTime": "2021-03-16T12:21:16.76" }, { "Id": "research-8_24711", "ContentId": "8_24711", "Headline": "Cavendish - Morning Note – 9 December 2020", "Synopsis": "", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-9-december-2020/8_24711?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ca5de4b5-06e9-4de9-87a6-17f0ad24fca7-stock-market-prices-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "SDI Group plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/industrial-equipment-goods-services/sdi-group-plc/SDI/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare Equipment & Services" ], "Id": "GB00B3FBWW43", "InternalId": "faf8097e-e8b4-4f82-bfa9-60c0b393fa49", "Isin": "GB00B3FBWW43", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Electrical and Electronic Equipment", "Ticker": "SDI:LON", "TIDM": "SDI", "BBTicker": "SDI", "AltTicker": "SDI", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 9, "TotalEventCount": 2, "TotalMediaCount": 3, "TotalResearchCount": 151, "TotalRnsCount": 262 } ], "Location": "International", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-12-09T07:42:09.137", "LastModifiedDateTime": "2020-12-09T09:07:50.57" }, { "Id": "research-8_23668", "ContentId": "8_23668", "Headline": "Cavendish - Morning Note – 28 October 2020", "Synopsis": "ANGLE (AGL): Corp | Chaarat Gold Holdings (CGH): Corp | Chariot Oil & Gas (CHAR): Corp | Omega Diagnostics (ODX): Corp | Shoe Zone (SHOE): Corp", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-28-october-2020/8_23668?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/b579ca8e-bcca-466a-9b40-4c340fdc48b0-financial-ticker-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Cambridge Nutritional Sciences PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cambridge-nutritional-sciences-plc/CNSL/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare Equipment & Services" ], "Id": "GB00B1VCP282", "InternalId": "4521e1cf-b329-408c-8c2f-d0c0dd4e91b6", "Isin": "GB00B1VCP282", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CNSL:LON", "TIDM": "CNSL", "BBTicker": "CNSL", "AltTicker": "CNSL", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 0, "TotalMediaCount": 4, "TotalResearchCount": 147, "TotalRnsCount": 493 }, { "CompanyName": "Chariot Limited", "CompanyUrl": "https://www.research-tree.com/companies/uk/energy/chariot-limited/CHAR/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Clean Energy" ], "Id": "GG00B2R9PM06", "InternalId": "592ef558-de39-4832-bfa3-7b7ab16daa00", "Isin": "GG00B2R9PM06", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Oil & Gas - E&Ps", "Ticker": "CHAR:LON", "TIDM": "CHAR", "BBTicker": "CHAR", "AltTicker": "CHAR", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 4, "TotalEventCount": 2, "TotalMediaCount": 33, "TotalResearchCount": 244, "TotalRnsCount": 407 } ], "Location": "International", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-10-28T07:37:46.037", "LastModifiedDateTime": "2020-10-28T08:57:22.99" }, { "Id": "research-8_23208", "ContentId": "8_23208", "Headline": "Cavendish - ANGLE - Placing raises £19.6m", "Synopsis": "ANGLE raised £19.6m (gross) to capitalise on the first-mover advantage that the FDA clearance for Parsortix will create, catalysing ANGLE’s ability to exploit the emerging multi-billion dollar liquid biopsy market. It will enable ANGLE to pursue multiple parallel revenue streams: (i) as a service provider to the pharma industry particularly looking to improve on immunotherapy patient outcomes (companion diagnostics) and (ii) to develop a number of specific clinical applications. Not only does it", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/cavendish/angle-placing-raises-19-6m/8_23208?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/4416f982-74ce-4bbf-8c59-67fbe2fa32fd-medical-equipment-services-2-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "International", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-10-28T07:32:29.383", "LastModifiedDateTime": "2020-10-28T08:54:55.28" }, { "Id": "media-8168", "ContentId": "8168", "Headline": "Proactive - ANGLE completes FDA submission for Parsortix system for metastatic breast cancer", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/8168", "ThumbnailUrl": "https://img.youtube.com/vi/EsOdI__S-PU/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-09-28T13:40:00", "LastModifiedDateTime": "2020-09-28T13:44:53.857" }, { "Id": "research-8_22926", "ContentId": "8_22926", "Headline": "Cavendish - Morning Note – 28 September 2020", "Synopsis": "

ANGLE (AGL): Corp | Avacta (AVCT): Corp | Open Orphan (ORPH): Corp | Surface Transforms (SCE): Corp | Tracsis (TRCS): Corp

", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-28-september-2020/8_22926?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ca5de4b5-06e9-4de9-87a6-17f0ad24fca7-stock-market-prices-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "hVIVO plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/other/hvivo-plc/HVO/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Life Sciences" ], "Id": "GB00B9275X97", "InternalId": "7448d974-7569-473d-b2da-14edce283089", "Isin": "GB00B9275X97", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Other", "Ticker": "HVO:LON", "TIDM": "HVO", "BBTicker": "HVO", "AltTicker": "HVO", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 4, "TotalEventCount": 7, "TotalMediaCount": 137, "TotalResearchCount": 160, "TotalRnsCount": 635 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-09-28T07:41:02.107", "LastModifiedDateTime": "2024-11-08T12:43:33.467" }, { "Id": "research-8_22842", "ContentId": "8_22842", "Headline": "Cavendish - Morning Note – 23 September 2020", "Synopsis": "

Allergy Therapeutics (AGY): Corp FY 2020 – record pre-R&D EBIT | Amino Technologies (AMO): Corp Argentinian software contract win | ANGLE (AGL): Corp Peer reviewed publication, using Parsortix in MBC  | Bigblu Broadband (BBB): Corp Quickline secures up to £6.1m of subsidy in Lincolnshire | Hardide (HDD): Corp Trading in line with a stronger Q1 expected | Trackwise Designs (TWD): Corp Interim results, new contracts boost confidence | Xeros (XS", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-23-september-2020/8_22842?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/b579ca8e-bcca-466a-9b40-4c340fdc48b0-financial-ticker-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Allergy Therapeutics plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/allergy-therapeutics-plc/AGY/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Pharmaceuticals & Biotechnology" ], "Id": "GB00B02LCQ05", "InternalId": "332e34b6-6705-4ff9-973b-1357c93950df", "Isin": "GB00B02LCQ05", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Pharmaceuticals", "Ticker": "AGY:LON", "TIDM": "AGY", "BBTicker": "AGY", "AltTicker": "AGY", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 24, "TotalEventCount": 6, "TotalMediaCount": 16, "TotalResearchCount": 219, "TotalRnsCount": 341 }, { "CompanyName": "Xeros Technology Group Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/industrial-equipment-goods-services/xeros-technology-group-plc/XSG/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Industrial Technology" ], "Id": "GB00BJFLLV84", "InternalId": "c2f03a95-74b5-4ece-87d7-8b3aa665c26b", "Isin": "GB00BMGYBJ57", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Industrials - Specialty & Parts", "Ticker": "XSG:LON", "TIDM": "XSG", "BBTicker": "XSG", "AltTicker": "XSG", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 1, "TotalEventCount": 2, "TotalMediaCount": 3, "TotalResearchCount": 70, "TotalRnsCount": 437 }, { "CompanyName": "Hardide plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/industrial-equipment-goods-services/hardide-plc/HDD/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Speciality Chemicals" ], "Id": "GB00BJJPX768", "InternalId": "41b44bd6-2b97-41c0-aa95-a31af9d7aa30", "Isin": "GB00BJJPX768", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Industrials - Specialty & Parts", "Ticker": "HDD:LON", "TIDM": "HDD", "BBTicker": "HDD", "AltTicker": "HDD", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 8, "TotalEventCount": 1, "TotalMediaCount": 7, "TotalResearchCount": 135, "TotalRnsCount": 204 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-09-23T07:36:21.263", "LastModifiedDateTime": "2020-09-23T10:50:48.747" }, { "Id": "media-7938", "ContentId": "7938", "Headline": "ANGLE PLC: Proactive One2One Virtual Conference", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/7938", "ThumbnailUrl": "https://img.youtube.com/vi/X-ux25RcGw4/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-08-29T11:07:00", "LastModifiedDateTime": "2020-08-29T11:11:10.037" }, { "Id": "research-8_21992", "ContentId": "8_21992", "Headline": "Cavendish - Morning Note – 14 August 2020", "Synopsis": "

ANGLE (AGL): Corp Peer-reviewed paper – cancer immunotherapy

", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/cavendish/morning-note-14-august-2020/8_21992?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/158fe0c8-21a5-4739-9ea5-1180902cbdbd-medical-equipment-services-5-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-08-14T07:33:50.96", "LastModifiedDateTime": "2020-08-14T11:56:24.843" }, { "Id": "research-8_21400", "ContentId": "8_21400", "Headline": "Cavendish - Morning Note – 20 July 2020", "Synopsis": "

ANGLE (AGL): Corp | ANGLE (AGL): Corp | Lok'nStore (LOK): Corp | Surface Transforms (SCE): Corp | Synairgen (SNG): Corp

", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-20-july-2020/8_21400?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ca5de4b5-06e9-4de9-87a6-17f0ad24fca7-stock-market-prices-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Europa Oil & Gas (Holdings) plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/chemicals/europa-oil-gas-holdings-plc/EOG/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Other" ], "Id": "GB00B03CJS30", "InternalId": "94cccd89-f1d0-4150-99ab-e09ade5a9bae", "Isin": "GB00B03CJS30", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Specialty Chemical", "Ticker": "EOG:LON", "TIDM": "EOG", "BBTicker": "EOG", "AltTicker": "EOG", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 3, "TotalEventCount": 4, "TotalMediaCount": 41, "TotalResearchCount": 149, "TotalRnsCount": 347 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-07-20T07:43:33.347", "LastModifiedDateTime": "2020-07-20T10:43:44.437" }, { "Id": "research-8_20888", "ContentId": "8_20888", "Headline": "Cavendish - Morning Note – 25 June 2020", "Synopsis": "

ANGLE (AGLE.L): Corp Prelims – back in the saddle post-COVID disruption | NAHL (NAH): Corp Battling through the short-term challenges | Transense Technologies (TRT): Corp Licence and transfer of iTrack to Bridgestone

", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-25-june-2020/8_20888?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/b579ca8e-bcca-466a-9b40-4c340fdc48b0-financial-ticker-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Transense Technologies PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/industrial-equipment-goods-services/transense-technologies-plc/TRT/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Industrial Technology" ], "Id": "GB00BDHDTH21", "InternalId": "3b69176f-eaac-49a6-95f4-917fc37fbb53", "Isin": "GB00BDHDTH21", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Electrical and Electronic Equipment", "Ticker": "TRT:LON", "TIDM": "TRT", "BBTicker": "TRT", "AltTicker": "TRT", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 3, "TotalEventCount": 5, "TotalMediaCount": 0, "TotalResearchCount": 86, "TotalRnsCount": 312 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-06-25T07:40:47.023", "LastModifiedDateTime": "2020-10-08T01:12:25.29" }, { "Id": "research-8_20812", "ContentId": "8_20812", "Headline": "Cavendish - ANGLE - Prelims – back in the saddle post-COVID disruption", "Synopsis": "

Having previously alerted the market to its change of year-end, ANGLE has reported preliminary eight-month results to 31 December 2019, with year-end cash of £18.8m excluding a £1.8m tax credit received in April. Following well-documented delays caused by COVID-19, and as already announced, FDA submission is on track to occur during Q3 2020, offering the prospect of clearance in Q1 2021. Meanwhile, the ovarian cancer triage test is expected to complete patient enrolment by year-en", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/cavendish/prelims-back-in-the-saddle-post-covid-disruption/8_20812?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/7f97e0ca-09a8-4bfa-8b3f-5448a65a8acb-medical-equipment-services-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-06-25T07:36:30.22", "LastModifiedDateTime": "2020-06-26T11:42:32.603" }, { "Id": "media-7406", "ContentId": "7406", "Headline": "Proactive - ANGLE PLC's Andrew Newland updates as blood donations restart to support its key studies", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/7406", "ThumbnailUrl": "https://img.youtube.com/vi/lZTtbUSzufg/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-06-22T12:20:00", "LastModifiedDateTime": "2020-06-22T12:23:44.117" }, { "Id": "research-8_20760", "ContentId": "8_20760", "Headline": "Cavendish - Morning Note – 22 June 2020", "Synopsis": "

ANGLE (AGLE.L): Corp | Omega Diagnostics (ODX): Corp | Surface Transforms (SCE): Corp | Touchstone Exploration (TXP): Corp | Trifast (TRI): Corp

", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-22-june-2020/8_20760?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/b579ca8e-bcca-466a-9b40-4c340fdc48b0-financial-ticker-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "Touchstone Exploration Inc", "CompanyUrl": "https://www.research-tree.com/companies/uk/energy/touchstone-exploration-inc/TXP/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Oil & Gas" ], "Id": "CA89156L1085", "InternalId": "e95603fa-a065-4978-82eb-c4c28fa022db", "Isin": "KK2N26-R ", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Oil & Gas - E&Ps", "Ticker": "TXP:LON", "TIDM": "TXP", "BBTicker": "TXP", "AltTicker": "TXP", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 40, "TotalResearchCount": 131, "TotalRnsCount": 475 }, { "CompanyName": "Trifast plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/resources/trifast-plc/TRI/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Industrial Engineering" ], "Id": "GB0008883927", "InternalId": "25e0668b-b1a1-45a5-af12-82fa505ab33e", "Isin": "GB0008883927", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Industrial Metals - Iron & Steel", "Ticker": "TRI:LON", "TIDM": "TRI", "BBTicker": "TRI", "AltTicker": "TRI", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 16, "TotalEventCount": 0, "TotalMediaCount": 21, "TotalResearchCount": 161, "TotalRnsCount": 362 }, { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Cambridge Nutritional Sciences PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cambridge-nutritional-sciences-plc/CNSL/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare Equipment & Services" ], "Id": "GB00B1VCP282", "InternalId": "4521e1cf-b329-408c-8c2f-d0c0dd4e91b6", "Isin": "GB00B1VCP282", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CNSL:LON", "TIDM": "CNSL", "BBTicker": "CNSL", "AltTicker": "CNSL", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 0, "TotalMediaCount": 4, "TotalResearchCount": 147, "TotalRnsCount": 493 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-06-22T07:36:30.173", "LastModifiedDateTime": "2020-06-22T11:07:28.847" }, { "Id": "research-8_19957", "ContentId": "8_19957", "Headline": "Cavendish - Morning Note – 12 May 2020", "Synopsis": "

ANGLE (AGL): Corp | Oncimmune Holdings (ONC): Corp

", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/companies/uk/medical-equipment-services/cellbxhealth-plc/research/referral/cavendish/morning-note-12-may-2020/8_19957?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/ca5de4b5-06e9-4de9-87a6-17f0ad24fca7-stock-market-prices-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-05-12T07:36:55.25", "LastModifiedDateTime": "2020-05-12T09:43:52.507" }, { "Id": "media-6943", "ContentId": "6943", "Headline": "Proactive - ANGLE CEO reports 'progress across multiple fronts' and talks big new opportunity in immunotherapy", "Synopsis": "", "ProviderName": "Proactive", "Url": "https://www.research-tree.com/media/referrer/6943", "ThumbnailUrl": "https://img.youtube.com/vi/z1LTl7c6Q7A/mqdefault.jpg", "ProviderLogoUrl": null, "ContentType": "Media", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 } ], "Location": "", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-04-28T14:05:00", "LastModifiedDateTime": "2020-04-28T14:10:56.077" }, { "Id": "research-8_19576", "ContentId": "8_19576", "Headline": "Cavendish - Morning Note – 28 April 2020", "Synopsis": "

ANGLE (AGL): Corp Progress report since COVID-19 lockdown | NAHL (NAH): Corp Navigating change in difficult markets | Omega Diagnostics (ODX): Corp VISITECT CD4 supply agreement with CHAI | Proactis (PHD): Corp Reset of banking facility | STM (STM): Corp Transitioning into new markets from a robust base | Universe Group (UNG): Corp Strong FY19 trading update, strong FY20 order book

", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-28-april-2020/8_19576?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/dfc4b5ba-a8a8-41e6-b1a6-1e372c0ca6ab-ticker-tape-on-building-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Cambridge Nutritional Sciences PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cambridge-nutritional-sciences-plc/CNSL/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare Equipment & Services" ], "Id": "GB00B1VCP282", "InternalId": "4521e1cf-b329-408c-8c2f-d0c0dd4e91b6", "Isin": "GB00B1VCP282", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CNSL:LON", "TIDM": "CNSL", "BBTicker": "CNSL", "AltTicker": "CNSL", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 0, "TotalMediaCount": 4, "TotalResearchCount": 147, "TotalRnsCount": 493 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-04-28T07:41:56.1", "LastModifiedDateTime": "2020-04-28T08:37:09.067" }, { "Id": "research-8_19283", "ContentId": "8_19283", "Headline": "Cavendish - Morning Note – 17 April 2020", "Synopsis": "

ANGLE (AGL): Corp Utility in Head & Neck Cancer – peer reviewed paper | Circassia Pharmaceuticals (CIR): Corp Strategic shift | KRM22 (KRM): Corp Consolidation of Irisium | SRT Marine Systems (SRT): Corp Bank backs recent raise with a further £2.5m of cash

", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-17-april-2020/8_19283?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/b579ca8e-bcca-466a-9b40-4c340fdc48b0-financial-ticker-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "SRT Marine Systems plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/telecoms/srt-marine-systems-plc/SRT/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Technology & Telecoms" ], "Id": "GB00B0M8KM36", "InternalId": "a533babf-5cbd-4f77-bc4b-5229862cbdc0", "Isin": "GB00B0M8KM36", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Telecoms - Equipment", "Ticker": "SRT:LON", "TIDM": "SRT", "BBTicker": "SRT", "AltTicker": "SRT", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 8, "TotalEventCount": 1, "TotalMediaCount": 12, "TotalResearchCount": 129, "TotalRnsCount": 258 }, { "CompanyName": "KRM22 Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/other/krm22-plc/KRM/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Software & Computer Services" ], "Id": "GB00BFM6WC61", "InternalId": "edd375f5-d2a0-45bd-9904-d0b15d99627a", "Isin": "GB00BFM6WC61", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Other", "Ticker": "KRM:LON", "TIDM": "KRM", "BBTicker": "KRM", "AltTicker": "KRM", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 0, "TotalEventCount": 0, "TotalMediaCount": 14, "TotalResearchCount": 86, "TotalRnsCount": 174 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-04-17T07:41:48.023", "LastModifiedDateTime": "2020-04-17T09:54:33.47" }, { "Id": "research-8_18743", "ContentId": "8_18743", "Headline": "Cavendish - Morning Note – 31 March 2020", "Synopsis": "

ANGLE (AGL): Corp | Europa Oil & Gas (EOG): Corp | Hardide (HDD): Corp | Intercede (IGP): Corp | M.P. Evans (MPE): Corp | Quixant (QXT): Corp | Synairgen (SNG): Corp | Tremor (TRMR): Corp | Trifast (TRI): Corp

", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-31-march-2020/8_18743?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/dfc4b5ba-a8a8-41e6-b1a6-1e372c0ca6ab-ticker-tape-on-building-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "Intercede Group plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/technology/intercede-group-plc/IGP/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Technology & Telecoms" ], "Id": "GB0003287249", "InternalId": "940ae491-e880-41de-bdcc-72b2e4c1d833", "Isin": "GB0003287249", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Software", "Ticker": "IGP:LON", "TIDM": "IGP", "BBTicker": "IGP", "AltTicker": "IGP", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 6, "TotalEventCount": 1, "TotalMediaCount": 10, "TotalResearchCount": 132, "TotalRnsCount": 264 }, { "CompanyName": "M.P. Evans Group PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/food-production/m-p-evans-group-plc/MPE/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Food Producers" ], "Id": "GB0007538100", "InternalId": "b7fa70d7-7d68-4c2e-b085-ec008a8a392a", "Isin": "GB0007538100", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Agriculture & Fishing", "Ticker": "MPE:LON", "TIDM": "MPE", "BBTicker": "MPE", "AltTicker": "MPE", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 6, "TotalEventCount": 2, "TotalMediaCount": 13, "TotalResearchCount": 129, "TotalRnsCount": 1139 }, { "CompanyName": "Trifast plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/resources/trifast-plc/TRI/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Industrial Engineering" ], "Id": "GB0008883927", "InternalId": "25e0668b-b1a1-45a5-af12-82fa505ab33e", "Isin": "GB0008883927", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Industrial Metals - Iron & Steel", "Ticker": "TRI:LON", "TIDM": "TRI", "BBTicker": "TRI", "AltTicker": "TRI", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 16, "TotalEventCount": 0, "TotalMediaCount": 21, "TotalResearchCount": 161, "TotalRnsCount": 362 }, { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Europa Oil & Gas (Holdings) plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/chemicals/europa-oil-gas-holdings-plc/EOG/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Other" ], "Id": "GB00B03CJS30", "InternalId": "94cccd89-f1d0-4150-99ab-e09ade5a9bae", "Isin": "GB00B03CJS30", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Specialty Chemical", "Ticker": "EOG:LON", "TIDM": "EOG", "BBTicker": "EOG", "AltTicker": "EOG", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 3, "TotalEventCount": 4, "TotalMediaCount": 41, "TotalResearchCount": 149, "TotalRnsCount": 347 }, { "CompanyName": "Nexteq PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/discretionary-personal-goods/nexteq-plc/NXQ/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Tech Hardware & Equipment" ], "Id": "GB00B99PCP71", "InternalId": "798447de-596e-4512-9f92-fa4b8a624d01", "Isin": "GB00B99PCP71", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Lifestyle Products", "Ticker": "NXQ:LON", "TIDM": "NXQ", "BBTicker": "NXQ", "AltTicker": "NXQ", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 3, "TotalEventCount": 0, "TotalMediaCount": 10, "TotalResearchCount": 125, "TotalRnsCount": 435 }, { "CompanyName": "Hardide plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/industrial-equipment-goods-services/hardide-plc/HDD/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Speciality Chemicals" ], "Id": "GB00BJJPX768", "InternalId": "41b44bd6-2b97-41c0-aa95-a31af9d7aa30", "Isin": "GB00BJJPX768", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Industrials - Specialty & Parts", "Ticker": "HDD:LON", "TIDM": "HDD", "BBTicker": "HDD", "AltTicker": "HDD", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 8, "TotalEventCount": 1, "TotalMediaCount": 7, "TotalResearchCount": 135, "TotalRnsCount": 204 }, { "CompanyName": "Nexxen International Ltd.", "CompanyUrl": "https://www.research-tree.com/companies/usa/technology/nexxen-international-ltd-/NEXN/NAS", "CurrentPrice": 0.0, "CustomSectors": [ "Technology & Telecoms" ], "Id": "QHP74H-R", "InternalId": "b2b9ce00-0596-4014-8400-a12b07a2e0ea", "Isin": "IL0012165630", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Software", "Ticker": "NEXN:NAS", "TIDM": "NEXN", "BBTicker": "NEXN", "AltTicker": "NEXN", "AltExchange": "US", "Exchange": "NAS", "TotalBlogCount": 22, "TotalEventCount": 0, "TotalMediaCount": 6, "TotalResearchCount": 111, "TotalRnsCount": 1243 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-03-31T07:54:03.037", "LastModifiedDateTime": "2020-03-31T09:34:20.747" }, { "Id": "research-8_18100", "ContentId": "8_18100", "Headline": "Cavendish - Morning Note – 3 March 2020", "Synopsis": "

ANGLE (AGL): Corp | Braemar (BMS): Corp | Destiny Pharma (DEST): Corp | Gooch & Housego (GHH): Corp | President Energy (PPC): Corp | 4imprint (FOUR): Corp | DX (DX): Corp | Xeros (XSG): Corp

", "ProviderName": "Cavendish", "Url": "https://www.research-tree.com/research/referral/cavendish/morning-note-3-march-2020/8_18100?partner=llms", "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/b579ca8e-bcca-466a-9b40-4c340fdc48b0-financial-ticker-board-1-21x6_m.jpg", "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/cavendish_alt. navy logo.jpg", "ContentType": "Research", "SubType": null, "Companies": [ { "CompanyName": "Gooch & Housego PLC", "CompanyUrl": "https://www.research-tree.com/companies/uk/discretionary-personal-goods/gooch-housego-plc/GHH/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Electronic & Electrical Equipment" ], "Id": "GB0002259116", "InternalId": "8ab95cf7-f38f-47d1-ad76-3720d62f5c85", "Isin": "GB0002259116", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Electronic Products", "Ticker": "GHH:LON", "TIDM": "GHH", "BBTicker": "GHH", "AltTicker": "GHH", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 5, "TotalEventCount": 1, "TotalMediaCount": 9, "TotalResearchCount": 170, "TotalRnsCount": 295 }, { "CompanyName": "CelLBxHealth plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/health/cellbxhealth-plc/CLBX/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Healthcare" ], "Id": "GB0034330679", "InternalId": "1b7561c6-7534-49ad-8444-9a25bf6e06c1", "Isin": "GB0034330679", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Medical Equipment & Services", "Ticker": "CLBX:LON", "TIDM": "CLBX", "BBTicker": "CLBX", "AltTicker": "CLBX", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 7, "TotalEventCount": 2, "TotalMediaCount": 35, "TotalResearchCount": 122, "TotalRnsCount": 400 }, { "CompanyName": "Xeros Technology Group Plc", "CompanyUrl": "https://www.research-tree.com/companies/uk/industrial-equipment-goods-services/xeros-technology-group-plc/XSG/LON", "CurrentPrice": 0.0, "CustomSectors": [ "Industrial Technology" ], "Id": "GB00BJFLLV84", "InternalId": "c2f03a95-74b5-4ece-87d7-8b3aa665c26b", "Isin": "GB00BMGYBJ57", "LastDateContentWasAdded": "0001-01-01T00:00:00", "LastDateContentWasChanged": "0001-01-01T00:00:00", "LastDateContentWasRemoved": "0001-01-01T00:00:00", "LatestRating": null, "LatestRatingDate": "0001-01-01T00:00:00", "Location": "Not Set", "MarketCap": 0.0, "PriceChg": 0.0, "PriceChgPercent": 0.0, "Sector": "Industrials - Specialty & Parts", "Ticker": "XSG:LON", "TIDM": "XSG", "BBTicker": "XSG", "AltTicker": "XSG", "AltExchange": "LN", "Exchange": "LON", "TotalBlogCount": 1, "TotalEventCount": 2, "TotalMediaCount": 3, "TotalResearchCount": 70, "TotalRnsCount": 437 } ], "Location": "Not Set", "CanDirectDownload": false, "LoggedInUserHasAccess": true, "IsPremiumOnly": false, "OnlyAvailableToPayingClients": false, "DirectDownloadUrl": null, "DirectDownloadViewerUrl": null, "PartnerViewerUrl": null, "PublishedDate": "2020-03-03T07:36:40.297", "LastModifiedDateTime": "2020-03-03T10:53:35.607" } ], "Message": null, "TotalItems": 157 }